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Executive Summary 
The Massachusetts demonstration under the Financial Alignment Initiative will contract 
with Medicare-Medicaid Plans (MMPs, hereafter referred to as One Care plans) to provide all 
Medicare and Medicaid services to full-benefit Medicare-Medicaid enrollees aged 21 to 64. The 
Centers for Medicare & Medicaid Services (CMS) and the Commonwealth of Massachusetts 
have established a Federal-State partnership to implement the demonstration, which includes a 
three-way contract between CMS, the Commonwealth, and participating One Care plans based 
on a capitated model of financing. Individuals enrolled in 1915(c) waivers for home and 
community-based services (HCBS) and a small number of individuals residing in an intermediate 
care facility for individuals with intellectual disabilities (ICF/IID) are not eligible to enroll in the 
demonstration. Benefits under the demonstration will be expanded to include services not 
previously available to the eligible population, including diversionary behavioral health services, 
community support services, and enhancements to existing State Plan services. The 
demonstration will operate in counties where at least one plan proposed coverage and passed the 
CMS/Commonwealth readiness review (CMS and Commonwealth of Massachusetts, 2012; 
hereafter, Memorandum of Understanding [MOU], 2012). These counties will be Essex, 
Franklin, Hampden, Hampshire, Middlesex, Norfolk, Plymouth (partial county), Suffolk, and 
Worcester. The demonstration began on October 1, 2013, and will continue until December 31, 
2016 (CMS communication, 5/29/13).  
CMS contracted with RTI International to monitor the implementation of all State 
demonstrations under the Financial Alignment Initiative, and to evaluate their impact on 
beneficiary experience, quality, utilization, and cost. The evaluation includes an aggregate 
evaluation and State-specific evaluations. This report describes the State-specific Evaluation 
Plan for the Massachusetts demonstration as of December 16, 2013. The evaluation activities 
may be revised if modifications are made to either the Massachusetts demonstration or to the 
activities described in the Aggregate Evaluation Plan (Walsh et al., 2013). Although this 
document will not be revised to address all changes that may occur, the annual and final 
evaluation reports will note areas where the evaluation as executed differs from this evaluation 
plan. 
The goals of the evaluation are to monitor demonstration implementation, evaluate the 
impact of the demonstration on the beneficiary experience, monitor unintended consequences, 
and monitor and evaluate the demonstration’s impact on a range of outcomes for the eligible 
population as a whole and for subpopulations (e.g., people with mental illness and/or substance 
use disorders and long-term services and supports (LTSS) recipients). To achieve these goals, 
RTI International will collect qualitative and quantitative data from Massachusetts each quarter; 
analyze Medicare and Medicaid enrollment and claims data; conduct site visits, beneficiary focus 
groups, and key informant interviews; and incorporate relevant findings from any beneficiary 
surveys conducted by other entities. Information from monitoring and evaluation activities will 
be reported in a 6-month initial implementation report to CMS and the Commonwealth, quarterly 
monitoring reports provided to CMS and the Commonwealth, annual reports and a final 
evaluation report. The key research questions and data sources for each are summarized in 
Table ES-1. 
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Table ES-1 













1) What are the primary design features of the 
Massachusetts demonstration, and how do they differ 
from the Commonwealth’s previous system? 
X X — X 
2) To what extent did Massachusetts implement the 
demonstration as designed? What factors contributed to 
successful implementation? What were the barriers to 
implementation?  
X — — X 
3) What impact does the Massachusetts demonstration 
have on the beneficiary experience overall and for 
beneficiary subgroups? Do beneficiaries perceive 
improvements in how they seek care, choice of care 
options, how care is delivered, personal health outcomes, 
and quality of life? 
X X — X 
4) What impact does the Massachusetts demonstration 
have on cost and is there evidence of cost savings in the 
Commonwealth? How long did it take to observe cost 
savings in the Commonwealth? How were these savings 
achieved in the Commonwealth? 
— — X — 
5) What impact does the Massachusetts demonstration 
have on utilization patterns in acute, long-term, and 
behavioral health services, overall and for beneficiary 
subgroups? 
X X X X 
6) What impact does the Massachusetts demonstration 
have on health care quality overall and for beneficiary 
subgroups? 
— — X X 
7) Does the Massachusetts demonstration change access 
to care for medical, behavioral health, long-term services 
and supports (LTSS) overall and for beneficiary 
subgroups? If so, how? 
X X X X 
8) What policies, procedures, or practices implemented 
by Massachusetts in its demonstration can inform 
adaptation or replication by other States?  
X X — X 
9) What strategies used or challenges encountered by 
Massachusetts in its demonstration can inform adaptation 
or replication by other States? 
X X — X 
— = not applicable. 
1 Demonstration statistics refer to data that the Commonwealth, CMS, or other entities will provide regarding topics, including 
enrollments, disenrollments, grievances, appeals, and the number of One Care plans. 
The principal focus of the evaluation will be at the State level. CMS has engaged an 
operations support contractor to monitor fulfillment of the demonstration requirements outlined 
in the MOU and three-way contracts, including One Care plan (or MMP)-level monitoring. RTI 
will integrate that information into the evaluation as appropriate. 
Demonstration Implementation. Evaluation of demonstration implementation will be 
based on case study methods and quantitative data analysis of enrollment patterns. We will 
monitor progress, revisions to the demonstration, and identify transferable lessons from the 
Massachusetts demonstration through the following: document review, ongoing submissions by 
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the Commonwealth through an online State Data Reporting System (e.g., enrollment and 
disenrollment statistics and qualitative updates on key aspects of implementation), quarterly key 
informant telephone interviews, and at least two sets of site visits. We will also monitor and 
evaluate several demonstration design features, including the Commonwealth’s progress 
developing an integrated delivery system, integrated delivery system supports, care 
coordination/case management, benefits and services, enrollment and access to care, beneficiary 
engagement and protections, financing, and payment elements. Table 6 in Section 3 of this 
report provides a list of the implementation tracking elements that we will monitor for each 
design feature. Examples of tracking elements include State efforts to build plan and provider 
core competencies for serving beneficiaries with various disability types; State requirements for 
coordination and integration of clinical, LTSS, and behavioral health services; documentation of 
coordination activities between One Care plans and community-based organizations; phase-in of 
new or enhanced benefits, and methods to communicate them to eligible populations; and 
strategies for expanding beneficiary access to demonstration benefits. 
The data we gather about implementation will be used for within-State and aggregate 
analyses, included in the 6-month implementation report to CMS and the Commonwealth and 
annual reports, and will provide context for all aspects of the evaluation. 
Beneficiary Experience. The impact of this demonstration on beneficiary experience is 
an important focus of the evaluation. Our framework for evaluating beneficiary experience is 
influenced by work conducted by the Center for Health Care Strategies (CHCS) on the elements 
of integration that directly affect beneficiary experience for Medicare-Medicaid enrollees. Table 
8 in Section 4 of this report aligns key elements identified in the CHCS framework with the 
demonstration design features listed in the demonstration implementation section. The goals of 
these analyses are to examine the beneficiary experience and how it varies by subpopulation, and 
whether the demonstration has had the desired impact on beneficiary outcomes, including quality 
of life.  
To understand beneficiary experience, we will monitor Commonwealth-reported data 
quarterly (e.g., reports of beneficiary engagement activities), and discuss issues related to the 
beneficiary experience during quarterly telephone follow-up calls and site visits with the 
Commonwealth and with stakeholders. We will also obtain data on grievances and appeals from 
CMS and, as available, other sources. Focus groups will include Medicare-Medicaid enrollees 
from a variety of subpopulations, such as people with mental health conditions, substance use 
disorders, LTSS needs, and multiple chronic conditions. Relevant demonstration statistics will be 
monitored quarterly and quantitative and qualitative analyses of the beneficiary experience will 
be included in annual State-specific reports and the final evaluation report.  
Analysis Overview. Quality, utilization, access to care, and cost will be monitored and 
evaluated using encounter, claims, and enrollment data for a 2-year predemonstration period and 
during the course of the demonstration. The evaluation will use an intent-to-treat (ITT) approach 
for the quantitative analyses, comparing the eligible population for the Commonwealth’s 
demonstration with a similar population that is not affected by the demonstration (i.e., a 
comparison group). Under the ITT framework, outcome analyses will include all beneficiaries 
eligible for the demonstration in the demonstration area, including those who opt out, participate 
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but then disenroll, and those who enroll but may not seek services, and a group of similar 
individuals in the comparison group. This approach diminishes the potential for selection bias 
and highlights the effect of the demonstration on all beneficiaries in the demonstration-eligible 
population. RTI will compare the characteristics of those who enroll with those who are eligible 
but do not enroll in the care model and conduct analyses to further explore demonstration effects 
on demonstration enrollees, acknowledging that selection bias must be taken into account in 
interpreting the results. 
Identifying Demonstration and Comparison Groups. To identify the population eligible 
for the demonstration, Massachusetts will submit demonstration evaluation (finder) files to RTI 
on a quarterly basis. RTI will use this information to identify the characteristics of eligible 
beneficiaries for the quantitative analysis. Section 4.2.2.1 of this report provides more detail on 
the contents of the demonstration evaluation (finder) files.  
Identifying the comparison group members will entail two steps: (1) selecting the 
geographic area from which the comparison group will be drawn and (2) identifying the 
individuals who will be included in the comparison group. Because most Massachusetts counties 
and demonstration-eligible beneficiaries will be included in the demonstration area, RTI will 
most likely identify a comparison group from out-of-State Metropolitan Statistical Areas 
(MSAs). We will use cluster analysis to identify potential comparison States and areas that are 
most similar to Massachusetts in regard to costs, care delivery arrangements, and State policy 
affecting Medicare-Medicaid enrollees. We will also consider including the nondemonstration 
Massachusetts counties in the comparison group, together with the out-of-State areas. If the 
Massachusetts demonstration is implemented in fewer counties than anticipated, we will consider 
whether we can identify a comparison group that draws beneficiaries from nondemonstration 
areas within the Commonwealth or from out of State that are similar to the demonstration areas.  
Once a comparison area is selected, all Medicare-Medicaid enrollees in those States or 
areas who meet the demonstration’s eligibility criteria will be selected for comparison group 
membership based on the intent-to-treat study design. The comparison group will be refreshed 
annually to incorporate new entrants into the eligible population as new individuals become 
eligible for the demonstration over time. We will use propensity-score weighting to adjust for 
differences in individual-level characteristics between the treatment and comparison group 
members, using beneficiary-level data (demographics, socioeconomic, health, and disability 
status) and county-level data (health care market and local economic characteristics). We will 
remove from the comparison group any beneficiaries with a propensity score lower than the 
lowest score found in the demonstration group. 
The comparison areas will be determined within the first year of implementation in order 
to use the timeliest data available. The comparison group members will be determined 
retrospectively at the end of each demonstration year, allowing us to include information on 
individuals newly eligible or ineligible for the demonstration during that year. 
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Analyses. Analyses of quality, utilization, and cost in the Massachusetts evaluation will 
consist of the following: 
1. A monitoring analysis to track quarterly changes in selected quality, utilization, and 
cost measures over the course of the Massachusetts demonstration.  
2. A descriptive analysis of quality, utilization, and cost measures with means and 
comparisons for subgroups of interest, including comparison group results, for annual 
reports. This analysis will focus on estimates for a broad range of quality, utilization, 
and cost measures, as well as changes in these measures across years or subgroups of 
interest within each year.  
3. Multivariate difference-in-differences analyses of quality, utilization, and cost 
measures using a comparison group. 
4. A calculation of savings twice during the demonstration. RTI is developing the 
methodology for evaluating savings for States implementing capitated model 
demonstrations, which will include an analysis of spending by program (Medicaid, 
Medicare Parts A & B services, Medicare Part D services).  
Subpopulation Analyses. For the Massachusetts demonstration, individuals with end stage 
renal disease (ESRD), people receiving behavioral health services, individuals with chronic 
physical conditions, and people receiving LTSS (including individuals with developmental 
disabilities in the community who are not in 1915(c) waivers) are subpopulations of interest for 
this evaluation. For these subpopulations and others, we will evaluate the impact of the 
demonstration on quality, utilization, and access to care for medical, LTSS, and behavioral 
health services, and also examine qualitative data gathered through interviews, focus groups, and 
surveys. Descriptive analyses for annual reports will present results on selected measures 
stratified by subpopulations (e.g., those using and not using behavioral health services, LTSS). 
Multivariate analyses performed for the final evaluation will account for differential effects for 
subpopulations to understand whether quality, utilization, and cost are higher or lower for these 
groups. 
Utilization and Access to Care. Medicare, Medicaid, and One Care plan encounter data 
will be used to evaluate changes in the levels and types of services used, ranging along a 
continuum from institutional care to care provided at home (see Table 15 of this report for more 
detail). We will also include a specific focus on mental health and substance use disorder 
prevention and treatment services and community support services, which will be expanded 
under the demonstration. 
Quality. Across all demonstrations, RTI will evaluate a core quality measure set for 
monitoring and evaluation purposes that are available through claims and encounter data. RTI 
will obtain these data from CMS (see Table 16 of this report). We will supplement these core 
measures with the following: 
• Additional quality measures specific to Massachusetts, which will be finalized within 
the first 6 months of implementation. 
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• Quality of life, satisfaction, and access to care information derived from the 
evaluation as discussed in Section 4.1 and Section 4.2.  
• HEDIS measures that One Care plans are required to submit, as outlined in the 
Medicare-Medicaid Capitated Financial Alignment Model Reporting Requirements 
(CMS, 2013). 
• Beneficiary surveys, such as HOS and CAHPS, that One Care plans are required to 
report to CMS.  
Cost. To determine annual total costs (overall and by payer), we will aggregate the 
Medicare and Medicaid per member per month (PMPM) payments paid to the One Care plans 
and the costs for the eligible population that is not enrolled in the demonstration, per the intent-
to-treat evaluation design. This approach will help us to detect overall cost impact and eliminate 
the effects of potential selection bias among beneficiaries who participate in the demonstration 
and those who opt out or disenroll. We will also include Part D PMPM and any PMPM 
reconciliation data provided by CMS in the final assessment of cost impact to ensure that all data 
are available. Cost savings will be calculated twice for capitated model demonstrations using a 
regression-based approach. The methodology for determining cost savings for capitated model 
demonstrations is currently under development and will be reviewed and approved by the CMS 
Office of the Actuary. 
Summary of Data Sources. Table ES-2 displays the sources of information the RTI 
evaluation team will use to monitor demonstration progress and evaluate the outcomes of the 
Financial Alignment Demonstrations. The table provides an overview of the data that 
Massachusetts will be asked to provide and evaluation activities in which State staff will 
participate. As shown in this table, the evaluation team will access claims, encounter, and other 
administrative data from CMS. These data, and how they will be used in the evaluation, are 
discussed in detail in this evaluation plan and in the Aggregate Evaluation Plan (Walsh et al., 
2013). 
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Table ES-2 
Sources of information for the evaluation of the Financial Alignment Demonstrations 
RTI will 
obtain data 
from: Type of data 
CMS ● Encounter data (Medicare Advantage, Medicaid, and One Care plans) 
● HEDIS measures 
● Results from HOS and CAHPS surveys 
● Medicare and Medicaid fee-for-service claims 
● Medicare Part D costs 
● Nursing Home data (MDS) 
● CMS-HCC and RXHCC risk scores  
● Demonstration quality measures that States are required to report to CMS (listed in 
MOU) 
● Demonstration quality measures that health plans are required to report to CMS (listed 
in three-way contracts or other guidance) 
● Other administrative data as available 
State ● Detailed description of State’s method for identifying eligible beneficiaries 
● File with monthly information identifying beneficiaries eligible for the demonstration 
(can be submitted monthly or quarterly)1 
● SDRS (described in detail in Section 4 of the Aggregate Evaluation Plan) quarterly 
submissions of demonstration updates including monthly statistics on enrollments, 
opt-outs, and disenrollments 
● Participation in key informant interviews and site visits conducted by RTI team 
● Results from surveys, focus groups, or other evaluation activities (e.g., EQRO or 
Ombuds reports) conducted or contracted by the State,2 if applicable 
● Other data State believes would benefit this evaluation, if applicable 
Other sources ● Results of focus groups conducted by RTI subcontractor (The Henne Group) 
● Grievances and appeals 
● Other sources of data, as available 
CAHPS = Consumer Assessment of Healthcare Providers and Systems; EQRO = external quality review 
organization; HCC = hierarchical condition category; HEDIS = Healthcare Effectiveness Data and Information Set; 
HOS = Health Outcomes Survey; MDS = Minimum Data Set; MMP = Medicare Medicaid Plan; RXHCC = 
prescription drug hierarchical condition category; SDRS = State Data Reporting System. 
1 These data, which include both those enrolled and those eligible but not enrolled, will be used (in combination with 
other data) to identify the characteristics of the total eligible and the enrolled population. More information is 
provided in Section 4 of this report. 
2 States are not required to conduct or contract for surveys or focus groups for the evaluation of this demonstration. 
However, if the State chooses to do so, the State can provide any resulting reports from its own independent 
evaluation activities for incorporation into this evaluation, as appropriate. 
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1. Introduction 
1.1 Purpose  
The Medicare-Medicaid Coordination Office (MMCO) and Innovation Center at the 
Centers for Medicare & Medicaid Services (CMS) have created the Financial Alignment 
Demonstrations for States to test integrated care models for Medicare-Medicaid enrollees. The 
goal of these Financial Alignment Demonstrations is to develop person-centered care delivery 
models integrating the full range of medical, behavioral health, and long-term services for 
Medicare-Medicaid enrollees, with the expectation that integrated delivery models would 
address the current challenges associated with the lack of coordination of Medicare and 
Medicaid benefits, financing, and incentives. 
CMS contracted with RTI International to monitor the implementation of the 
demonstrations and to evaluate their impact on quality, utilization, and cost. The evaluation 
includes an aggregate evaluation and State-specific evaluations. 
This report describes the State-specific Evaluation Plan for the Massachusetts 
demonstration as of December 23, 2013. The evaluation activities may be revised if 
modifications are made to either the Massachusetts demonstration or to the activities described in 
the Aggregate Evaluation Plan (Walsh et al., 2013). Although this document will not be revised 
to address all changes that may occur, the annual and final evaluation reports will note areas 
where the evaluation as executed differs from this evaluation plan. This report provides an 
overview of the Massachusetts demonstration and provides detailed information on the 
framework for quantitative and qualitative data collection; the data sources, including data 
collected through RTI’s State Data Reporting System (described in Section 3.5, Progress 
Indicators, and in detail in the Aggregate Evaluation Plan [Walsh et al., 2013]); and impact and 
outcome analysis (i.e., the impact on beneficiary experience and quality, utilization, access to 
care, and costs) that will be tailored to Massachusetts.  
1.2 Research Questions 
The major research questions of the Massachusetts evaluation are presented in Table 1 
with an identification of possible data sources. The evaluation will use multiple approaches and 
data sources to address these questions. These are described in more detail in Sections 3 and 4 of 
this report.  
Unless otherwise referenced, the summary of the Massachusetts demonstration is based 
on the Commonwealth’s proposal submitted to CMS on February 16, 2012 (Commonwealth of 
Massachusetts, 2012a); the Commonwealth’s Memorandum of Understanding (MOU) with CMS 
(CMS and Commonwealth of Massachusetts, 2012; hereafter, MOU, 2012); the Request for 
Responses from Integrated Care Organizations (Commonwealth of Massachusetts and CMS, 
2012c; hereafter, RFR, 2012); and an Addendum to the State Demonstration to Integrate Care for 
Dual Eligible Individuals (Commonwealth of Massachusetts, 2012b; hereafter, Addendum, 2012.  
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Table 1  













1) What are the primary design features of the 
Massachusetts demonstration, and how do they differ 
from the Commonwealth’s previous system? 
X X — X 
2) To what extent did Massachusetts implement the 
demonstration as designed? What factors contributed to 
successful implementation? What were the barriers to 
implementation?  
X — — X 
3) What impact does the Massachusetts demonstration 
have on the beneficiary experience overall and for 
beneficiary subgroups? Do beneficiaries perceive 
improvements in how they seek care, choice of care 
options, how care is delivered, personal health outcomes, 
and quality of life? 
X X — X 
4) What impact does the Massachusetts demonstration 
have on cost and is there evidence of cost savings in the 
Commonwealth? How long did it take to observe cost 
savings in the Commonwealth? How were these savings 
achieved in the Commonwealth? 
— — X — 
5) What impact does the Massachusetts demonstration 
have on utilization patterns in acute, long-term, and 
behavioral health services, overall and for beneficiary 
subgroups? 
X X X X 
6) What impact does the Massachusetts demonstration 
have on health care quality overall and for beneficiary 
subgroups? 
— — X X 
7) Does the Massachusetts demonstration change access 
to care for medical, behavioral health, long-term services 
and supports (LTSS) overall and for beneficiary 
subgroups? If so, how? 
X X X X 
8) What policies, procedures, or practices implemented 
by Massachusetts in its demonstration can inform 
adaptation or replication by other States?  
X X — X 
9) What strategies used or challenges encountered by 
Massachusetts in its demonstration can inform adaptation 
or replication by other States? 
X X — X 
N/A = not applicable. 
1 Demonstration statistics refer to data that the Commonwealth, CMS, or other entities will provide regarding topics, 
including enrollments, disenrollments, grievances, appeals, and the number of One Care plans.  
The details of the evaluation design are covered in the three major sections that follow: 
● An overview of the Massachusetts demonstration 
● Demonstration implementation, evaluation and monitoring 
● Impact and outcome evaluation and monitoring. 
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2. Massachusetts Demonstration 
2.1 Demonstration Goals 
The goals of the Massachusetts demonstration are “to alleviate the fragmentation and 
improve coordination of services for Medicare-Medicaid Enrollees, enhance quality of care and 
reduce costs for both the Commonwealth and the Federal government” (Memorandum of 
Understanding [MOU], 2012, p. 2). Key objectives of the demonstration are “to improve the 
beneficiary experience in accessing care, deliver person-centered care, promote independence in 
the community, improve quality, eliminate cost shifting between Medicare and Medicaid and 
achieve cost savings for the Commonwealth and Federal government through improvements in 
care and coordination. CMS and the Commonwealth expect this model of integrated care and 
financing to, among other things, improve quality of care and reduce health disparities, meet 
both health and functional needs, and improve transitions among care settings. Meeting 
beneficiary needs, including the ability to self-direct care, be involved in one’s care, and live 
independently in the community, are central goals of this initiative” (MOU, 2012, p. 3). 
2.2 Summary of Demonstration 
Massachusetts and CMS have contracted with Medicare-Medicaid Plans (MMPs; 
hereafter referred to as One Care plans), to provide Medicare and Medicaid services for full-
benefit Medicare-Medicaid enrollees aged 21 to 64 at the time of enrollment who are not 
enrolled in Home and Community-Based Services (HCBS) waivers, are not residing in an 
intermediate care facility for individuals with intellectual disabilities (ICF/IID), do not have 
other comprehensive insurance, and meet other eligibility criteria as described in the MOU. The 
demonstration will operate in counties in which at least one plan proposed coverage and passed 
the CMS/Commonwealth readiness review (CMS and Commonwealth of Massachusetts, 2012; 
hereafter, MOU, 2012). These counties will be Essex, Franklin, Hampden, Hampshire, 
Middlesex, Norfolk, Plymouth (partial county), Suffolk, and Worcester. The demonstration 
began on October 1, 2013, and will continue until December 31, 2016 (CMS communication, 
5/29/13).  
Benefits for individuals enrolled in the demonstration will include all Medicare and 
Medicaid services, as well as services not previously available to these beneficiaries, including 
diversionary behavioral health services (e.g., community crisis stabilization, partial 
hospitalization, acute treatment and clinical support for substance abuse), community support 
services (e.g., home care services, peer support/counseling/navigation, care transition assistance), 
and enhancements to existing State Plan services (e.g., preventive, restorative, and emergency 
oral health; cueing and supervision for personal care services) (MOU, 2012, pp. 69–81). “[One 
Care plans] will offer care coordination services to all Enrollees through a Care Coordinator or 
Clinical Care Manager, for medical and behavioral health services; and through an Independent 
Living and Long-Term Services and Supports (IL-LTSS) Coordinator contracted from a 
community-based organization, for LTSS. The IL-LTSS Coordinator [will] be a full member of 
the Interdisciplinary Care Team as appropriate, serving at the discretion of the Enrollee” (MOU, 
2012, p. 58). 
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Beneficiaries will be offered a choice of One Care plans in their service area, or to opt out 
of the demonstration. Those who do not select a One Care plan and do not opt out of the 
demonstration may be passively enrolled in the demonstration and assigned to a One Care plan. 
Prior to the effective date of passive enrollment, individuals will have a period of at least 60 days 
to choose a different One Care plan or opt out of the demonstration. 
To participate in the demonstration, One Care plans had to meet the Commonwealth’s 
requirements set forth in the Massachusetts Request for Responses (RFR) (RFR, 2012); CMS 
requirements outlined in capitated Financial Alignment Demonstration guidance; and pass a joint 
CMS/Commonwealth readiness review. Both existing organizations and newly formed 
organizations were eligible to apply to be One Care plans. Selected One Care plans will be 
responsible for the delivery and management of all Medicaid, Medicare, and new and expanded 
services for demonstration enrollees, with the exception of Targeted Case Management (TCM) 
services provided by the Massachusetts Department of Mental Health (DMH) and the 
Department of Developmental Services (DDS) or rehabilitation option services purchased by 
DMH (MOU, 2012, p. 82). TCM and rehabilitation option services will not be included in the 
capitated rate, and will continue to be provided on an FFS basis to demonstration enrollees. 
Capitation payments to the One Care plans are described and agreed to in three-way 
contracts among CMS, the Commonwealth, and participating One Care plans. The goal of the 
integrated capitation payments is to test a new payment methodology that will minimize cost 
shifting, align incentives between Medicare and Medicaid, and support the best possible 
outcomes for enrollees (MOU, 2012, p. 3). 
Table 2 provides a summary of the key characteristics of the Massachusetts 
demonstration compared with the system that currently exists for demonstration-eligible 
beneficiaries. 
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Table 2 
Key features of Massachusetts model predemonstration and during the demonstration  
Key features Predemonstration Demonstration1 
Summary of covered benefits 
Medicare 
 
Medicare Parts A, B, and D 
 
Medicare Parts A, B, and D. Exclusions are listed 
below. 
Medicaid Medicaid State Plan Medicaid State Plan services, as well as new 
diversionary behavioral health and community 
support services, and expanded State Plan services 
(e.g., dental, DME services). Exclusions are listed 
below.  





Mostly FFS; very small 
percentage in Medicare 









Capitated. Medicare hospice services remain FFS 
(as in Medicare Advantage). 
Behavioral health FFS Capitated. Service exclusions: TCM for 
beneficiaries with SPMI or developmental 
disabilities and rehabilitation option services for 
beneficiaries with SPMI are not included in the 
capitation rate under the demonstration. The 
Commonwealth continues to provide this service 
on an FFS basis.  
LTSS  FFS Capitated. Individuals enrolled in 1915(c) HCBS 
waivers and individuals residing in ICF/IIDs are 





Not available to the eligible 
population; some services 
available via HCBS waivers 
or managed care plans. 
 
Capitated 
 Expanded services 
including preventive, 
restorative, and 
emergency oral health 
benefits; personal care 
assistance that may be 
hands on or cueing and 
supervision) 
No  Capitated 
(continued) 
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Table 2 (continued) 
Key features of Massachusetts model predemonstration and during the demonstration 
Key features Predemonstration Demonstration1 
 Community Support 
Services (day services, 
home care services, 







Not available to the eligible 
population; some services 
available via HCBS waivers 




Care coordination for medical, 




Medical homes provide some 
care coordination for medical 
and behavioral services. 
 
 
One Care plans will offer care coordination 
through a care coordinator or clinical care manager 
for medical and behavioral health services; and 
through an IL-LTSS coordinator, contracted from 
a community-based organization, for LTSS.  
Care coordination/case 
management for HCBS 
waivers and by whom 
Case management of LTSS 
via HCBS waivers operated 
by Department of 
Developmental Services 
(DDS), The Massachusetts 
Rehabilitation Commission 
and the Executive Office of 
Elder Services.2 
People enrolled in HCBS waivers are not eligible 
for the demonstration.  
Targeted Case Management  Provided to certain 
individuals served by DDS 
and DMH.3  
No change; TCM is not included in the capitation 
rate under the demonstration. The Commonwealth 
continues to provide this service on an FFS basis. 
People receiving TCM are eligible to participate in 
the demonstration.  
Rehabilitation Option services Provided through DMH 
contractors to clients of 
DMH.3 
No change; Rehabilitation Option services are not 
included as covered service in the capitation rate. 
The Commonwealth continues to provide on an 
FFS basis. People receiving Rehabilitation Option 
services are eligible to participate in the 
demonstration.  
Clinical, integrated, or 
intensive care management 
None Primary care provider, with One Care plan 
support, will provide clinical care management for 
individuals with multiple chronic conditions, 
prescription drugs, or at high risk. Care 
coordinators for enrollees with complex clinical 
care needs will be clinical care managers.  
(continued) 
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Table 2 (continued) 
Key features of Massachusetts model predemonstration and during the demonstration 






Beneficiaries are offered a choice of One Care 
plan, or to opt out of the demonstration and 
remain in FFS (or join Medicare Advantage or 
another program, if applicable). Those who do not 
select a One Care plan and who do not opt out are 
passively enrolled in the demonstration, and can 
change One Care plans or opt out of the 
demonstration on a monthly basis.  
Attribution/assignment method N/A Beneficiaries who do not opt out or make an 
affirmative choice of a One Care plan are auto-






9 counties: Essex, Franklin, Hampden, Hampshire, 
Middlesex, Norfolk, Plymouth (partial), Suffolk, 
Worcester. 
Phase-in plan N/A The first enrollment period will be opt-in only. 
Beneficiaries will be offered the opportunity to 
select a One Care plan or indicate that they will 
opt out of the demonstration. First enrollments 
will take effect no sooner than October 1, 2013. 
Subsequently, there will be at least two passive 
enrollment periods, with tentative effective 
enrollment dates of January 1, 2014, and April 1, 
2014, first.  
Implementation date N/A The first effective enrollment date will be no 
sooner than October 1, 2013, for beneficiaries who 
opt into the demonstration.  
DMH = Department of Mental Health; FFS = fee-for-service; HCBS = home and community-based services; ICF/IID = 
intermediate care facility for individuals with intellectual disabilities; LTSS = long-term services and supports; MFFS = managed 
fee for service; N/A = not applicable; SPMI – severe and persistent mental illness; TCM = targeted case management. 
1 Information related to the Demonstration in this table is from the Memorandum of Understanding between Centers for Medicare 
& Medicaid Services and the Commonwealth of Massachusetts; dated August 22, 2012 (MOU, 2012).  
2 Commonwealth of Massachusetts, 2012b, p.1; hereafter, Addendum, 2012. 
3 Addendum, 2012, p 3. 
Individuals aged 21 through 64 at the time of enrollment who are enrolled in Medicare 
Parts A and B and eligible for Medicare Part D, who are enrolled in MassHealth Standard (the 
Massachusetts Medicaid program, operating under a §1115(a) waiver) or CommonHealth,1 and 
who have no other comprehensive private or public insurance will be eligible for enrollment in 
this demonstration (MOU, 2012, p. 8). Beneficiaries who are enrolled in an HCBS waiver or 
who are residents of an ICF/ID are not eligible to enroll in the demonstration, although the 
                                                 
1 CommonHealth is an expansion program for working and nonworking people with disabilities authorized through 
the MassHealth §1115 demonstration. 
Measurement, Monitoring, and Evaluation of State  
Demonstrations to Integrate Care for Dual Eligible Individuals 2. Massachusetts Demonstration 
Massachusetts Evaluation Design Plan — December 23, 2013 8 
Commonwealth is considering phasing in the HCBS waiver enrollees later. Beneficiaries who 
turn 65 while enrolled in the demonstration will be able to choose to remain in the 
demonstration, return to FFS Medicare and Medicaid, join a Medicare Advantage plan or the 
Program of All-inclusive Care for the Elderly (PACE), or participate in another program, if 
applicable. Eligible beneficiaries who are enrolled in a Medicare Advantage or PACE plan, 
Employer Group Waiver Plans (EGWP), other employer-sponsored plans, plans receiving a 
Retiree Drug Subsidy, or individuals participating in the CMS Independence at Home 
demonstration may enroll in the Financial Alignment Demonstration if they choose to disenroll 
from their existing programs (MOU, 2012, p. 8).  
Providers serving as Medicare Pioneer or Shared Savings Program Accountable Care 
Organizations (ACOs) may contract with One Care plans as network providers and serve 
Medicare-Medicaid enrollees under the Financial Alignment Demonstration, but these providers 
will not be eligible to earn Medicare shared savings payments from CMS for beneficiaries who 
are enrolled in the Financial Alignment Demonstration. Massachusetts encourages One Care 
plans to enter into alternative payment arrangements with contracted providers, including 
providers also serving as ACOs, that will advance the demonstration delivery system 
innovations, incentivize quality care, and improve health outcomes for demonstration enrollees. 
The characteristics of the population eligible to participate in the demonstration are 
presented in Table 3. Approximately 98.5 percent of the eligible population resides in the 
community and 1.5 percent of the individuals reside in a facility. Of those residing in the 
community, approximately 41 percent of the individuals had a severe and persistent mental 
illness and 34 percent had a substance use disorder. Fifty-six percent had a chronic physical 
condition, and 8 percent had an intellectual disability. Of those residing in a facility, 60 percent 
had a severe and persistent mental illness, 24 percent had a substance use disorder, 76 percent 
had a chronic physical condition, and 10 percent had an intellectual disability2 (Commonwealth 
of Massachusetts, 2013).  
  
                                                 
2 Individuals can have more than one condition; thus the sum of the percentages for the characteristics of the 
eligible population will be greater than 100 percent.  
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Table 3 
Characteristics of eligible population1 for December 2012  
Condition No. of beneficiaries 
Percentage of eligible 
population 
Population residing in a facility2 1,608 1.5%  
Severe and persistent mental illness3,4 — 60% 
Substance use condition3 — 24% 
Chronic physical condition3,5 — 76% 
Intellectual disability3 — 10% 
Population residing in the community 107,245 98.5%  
Severe and persistent mental illness3,4 — 41% 
Substance use condition3 — 34% 
Chronic physical condition3,5 — 56% 
Intellectual disability3 — 8% 
Total individuals potentially eligible for demonstration 
(Medicare-Medicaid enrollees aged 21 to 64) 
108,853 100.0%  
— = not available. 
1 Includes individuals 21–64 years old who are enrolled in Medicare Parts A and B, eligible for Medicare Part D, 
receiving MassHealth Standard or CommonHealth, and have no other comprehensive coverage. These numbers 
include beneficiaries throughout the Commonwealth, and are not limited to the counties served by One Care plans in 
2013. 
2 Facility residence includes individuals with extended episodes of care in any of the following: Intermediate Care 
Facility, Skilled Nursing Facility, Chronic Disease Hospital, Psychiatric Hospital, or Rehabilitation Hospital. 
3 Conditions based on Verisk Health’s DxCG Risk Solutions software. Individuals can have more than one 
condition; thus the sum of the percentages for the characteristics of the eligible population will be greater than 100 
percent. 
4 Includes Schizophrenia, and Major Depressive, Bipolar and Paranoid Disorders.  
5 Includes Asthma, Diabetes, COPD, CHF, Hypertension, Arthritis and Coronary Artery Disease.  
SOURCE: Commonwealth of Massachusetts, Executive Office of Health and Human Services. Office of Medicaid. 
Boston, MA (September 4, 2013). 
Although Massachusetts will not include TCM services or Rehabilitation Option services 
in the capitation rate, the people receiving those services will be eligible for the demonstration 
(as long as they meet demonstration eligibility criteria). Their other services (e.g., medical, acute, 
community LTSS) will be managed and paid for by the One Care plans, whereas TCM and 
Rehabilitation Option services will continue to be purchased separately by the Commonwealth 
agencies. Massachusetts stresses the importance of including people receiving these services in 
the demonstration because they will be able to access the integrated diversionary behavioral 
health services that are not available in the fee-for-service (FFS) system. Massachusetts indicated 
that approximately 8,046 individuals (who were not on HCBS waivers) used TCM in 2009 and 
used approximately $24.5 million in nonwaiver services. The same year, 2,565 Department of 
Mental Health clients used approximately $37.5 million in services (including the Rehabilitation 
Option and the TCM) (Addendum, 2012, p. 3).  
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As shown in Table 4, the total Medicare and Medicaid spending on Medicare-Medicaid 
enrollees aged 21 to 64 was $2.6 billion in CY 2008. This spending was roughly evenly divided 
between the two programs. Total Medicare and Medicaid spending for those enrolled in HCBS 
waivers (aged 18 to 64) was $569 million; as noted, this population will not be eligible for the 
demonstration (not shown) (Massachusetts proposal, p. 6). 
Table 4 








Eligible population $1.305 billion $1.319 billion $2.624 billion 
NOTE: These numbers include beneficiaries throughout the Commonwealth, and are not limited to the counties 
served by One Care plans in 2013. 
SOURCE: Commonwealth of Massachusetts, Executive Office of Health and Human Services. Office of Medicaid: 
State demonstration to integrate care for dual eligible individuals: Proposal to the Center for Medicare and Medicaid 
Innovation. (Contract No. HHSM-500-2011-00033C). Boston, MA, Massachusetts Office of Health and Human 
Services; February 16, 2012; pp. 5 and 6. These data include expenditures for HCBS Waiver enrollees. 
2.3 Relevant Historical and Current Context  
History/Experience with Managed Care. Massachusetts has extensive experience with 
the design, implementation, and operation of managed care for Medicare-Medicaid enrollees and 
Medicaid-only individuals. The Massachusetts demonstration builds on the Commonwealth’s 
experience with two programs that serve Medicare-Medicaid enrollees: the PACE program and 
the Senior Care Options (SCO) program. PACE programs first were implemented in 
Massachusetts in 1990, and five such programs now serve individuals 55 or older. The SCO 
program was implemented in 2004 and has enrolled more than 18,000 individuals aged 65 or 
older. The PACE and SCO programs include comprehensive, integrated, managed care plans that 
include all services covered by Medicare and MassHealth. The five SCO organizations in 
Massachusetts operate “as Medicare Advantage duals special needs plans (D-SNPs) and as 
Medicaid Managed Care plans” (Commonwealth of Massachusetts, 2012a). 
Massachusetts also has experience with managed care for individuals who have only 
Medicaid benefits. Under its §1115(a) demonstration, the Commonwealth operates a behavioral 
health plan for MassHealth-only members who are enrolled in the Primary Care Clinician Plan 
(PCCP), and the Commonwealth contracts with other managed care organizations for Medicaid-
only members enrolled in managed care.  
Other Initiatives. The Massachusetts demonstration is part of a larger health care reform 
strategy to transform the Commonwealth’s health care system. Phase I of the reform began in 
2006 with passage of a health care reform law to expand access to health care insurance, 
resulting in coverage of 98 percent of the population by 2012 (Massachusetts Proposal, 2012b, 
p. 20). The law also created the Health Care Quality and Cost Council, which is directed to 
establish goals for improving health care quality, containing costs, and reducing racial and ethnic 
disparities in health care; to demonstrate progress in meeting those goals; and to disseminate 
comparative cost and quality information on its website. Phase II focuses on innovative delivery 
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system and payment reforms designed to improve quality, expand access to care coordination, 
enhance accountability, and reduce costs. The Commonwealth administration is promoting a 
shift across all sectors of the health care system from fee-for-service payment to global 
payments.  
Several other initiatives in the Commonwealth are aligned with the goals of the 
demonstration. These include the Patient-Centered Medical Home Initiative (PCMHI), the 
development of Medicaid accountable care organizations, the implementation of the Money 
Follows the Person (MFP) rebalancing demonstration, bundled payment pilots in MassHealth, 
and exploration of Medicaid Health Homes. 
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3. Demonstration Implementation Evaluation 
3.1 Purpose 
The evaluation of the implementation process is designed to answer the following 
overarching questions about the Massachusetts demonstration: 
• What are the primary design features of the Massachusetts demonstration, and how 
do they differ from the Commonwealth’s previous system available to the 
demonstration eligible population? 
• To what extent did Massachusetts implement the demonstration as designed? What 
factors contributed to successful implementation? What were the barriers to 
implementation? 
• What Commonwealth policies, procedures, or practices implemented by 
Massachusetts can inform adaptation or replication by other States?  
• Was the demonstration more easily implemented for certain subgroups? 
• How have beneficiaries participated in the ongoing implementation and monitoring of 
the demonstration? 
• What strategies used or challenges encountered by Massachusetts can inform 
adaptation or replication by other States? 
3.2 Approach  
The evaluation team will examine whether the demonstration was implemented as 
designed and will look at modifications to the design features that were made during 
implementation; any changes in the time frame or phase-in of the demonstration; and other 
factors that facilitated or impeded implementation. This section will discuss the following:  
• Monitoring implementation of the demonstration by key demonstration design 
features 
• Implementation tracking elements 
• Progress indicators 
• Data sources 
• Interview questions and implementation reports  
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3.3 Monitoring Implementation of the Demonstration by Key 
Demonstration Design Features 
The major design features of the Massachusetts demonstration are described using a 
common framework that RTI will apply to all of the Financial Alignment demonstrations as 
follows:  
• Integrated delivery system 
• Integrated delivery system supports 
• Care coordination/case management 
• Benefits and services 
• Enrollment and access to care 
• Beneficiary engagement and protections 
• Financing and payment 
• Payment elements 
Our analysis of the implementation of the Massachusetts demonstration will be organized 
by these key demonstration design features. This framework will be used to define our areas of 
inquiry, structure the demonstration variables we track, organize information from our data 
collection sources, and outline our annual report. Table 5 illustrates the key components of each 
design feature that we will monitor as part of the implementation evaluation.  
Table 5 
Demonstration design features and key components 
Design feature Key components 
Core components of integrated delivery 
systems (how the delivery system is 
organized/integrated; interrelationships 
among the core delivery system 
components)  
● One Care plans 
● Primary care, including medical homes  
● LTSS 
● Behavioral health services 
● Developmental disability services 
● Integration functions that bridge delivery systems and roles 
of community-based organizations 
 (continued) 
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Table 5 (continued) 
Demonstration design features and key components 
Design feature Key components 
Integrated delivery systems supports ● Care team composition 
● Health IT applied throughout the demonstration (at 
Commonwealth level, by One Care plans, at provider level 
or other) 
● Data (Medicare claims or encounter data) and other 
feedback to One Care plans, medical homes, other providers 
(by the Commonwealth or other entities) 
● Primary care practice support (e.g., coaching, learning 
collaboratives, training) 
Care coordination/case management (by 
subpopulation and/or for special services) 
● Medical/primary 
● LTSS 
● Behavioral health services 
● Integration of care coordination 
Benefits and services 
● Assessment process 
● Service planning process 
● Care management targeting process 
● Support of care transitions across settings 
● Communication and hand-offs between care coordinators/ 
case managers and providers 
● Scope of services/benefits 
● New or enhanced services 
● Excluded services 
● Service authorization process 
Enrollment and access to care ● Integrated enrollment and access 
● Provider accessibility standards 
● Marketing/education protocols 
● Enrollment brokers 
● Beneficiary information and options counseling 
● Opt-out, disenrollment, and auto-assignment policy 
● Assignment/referrals to providers and medical homes 
● Phased enrollment of eligible populations 
● Workforce development for worker supply and new 
functions 
Beneficiary engagement and protections ● Commonwealth policies to integrate Medicare and 
Medicaid grievances and appeals 
● Quality management systems 
● Ongoing methods for engaging beneficiary organizations in 
policy decisions and implementation 
● Approaches to capture beneficiary experience, such as 
surveys and focus groups 
 (continued) 
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Table 5 (continued) 
Demonstration design features and key components 
Design feature Key components 
Demonstration financing model and 
methods of payment to plans and 
providers 
● Financing model—capitation 
● Entities to which the Commonwealth is directly making 
payments 
● Innovative payment methods to One Care plans and/or to 
providers 
Elements of payments to One Care plans 
and providers 
● Incentives 
● Shared savings 
● Risk adjustment 
IT = information technology; LTSS = long-term services and supports. 
3.4 Implementation Tracking Elements 
Through document review and interviews with Commonwealth agency staff, we will 
identify and describe the delivery system for Medicare-Medicaid enrollees in the eligible 
population. This will enable us to identify key elements that Massachusetts intends to modify 
through the demonstration and measure the effects of those changes. Using a combination of 
case study methods, including document review, and telephone interviews, we will conduct a 
descriptive analysis of the Commonwealth’s key demonstration features.  
The evaluation will analyze how Massachusetts is carrying out its implementation plan 
and track any changes it makes to its initial design as implementation proceeds. We will identify 
both planned changes that are part of the demonstration design (e.g., phasing in new populations) 
and operational and policy modifications Massachusetts makes based on changing 
circumstances. Finally, we anticipate that, in some instances, changes in the policy environment 
in the Commonwealth will trigger alterations to the original demonstration design.  
During site visit interviews and our ongoing communication with the Commonwealth, we 
will collect detailed information on how Massachusetts has structured care coordination for 
beneficiaries enrolled in the demonstration. The evaluation will analyze the scope of care 
coordination responsibilities assigned to One Care plans, the extent to which they conduct these 
functions directly or through contract, and internal structures established to promote service 
integration. We will also identify ways that the scope of care coordination activities conducted 
under the demonstration by One Care plans compares to the Commonwealth’s approach in their 
capitated managed care programs serving other populations. 
We will also collect data from the Commonwealth to track implementation through the 
State Data Reporting System (SDRS). The Commonwealth will submit quarterly demonstration 
statistics and qualitative updates through the SDRS (described in Section 3.5, Progress 
Indicators, and in detail in the Aggregate Evaluation Plan [Walsh et al., 2013]). RTI will 
generate reports based on these data and conduct telephone calls with the Commonwealth 
demonstration director as needed to understand the Massachusetts entries. We will make 
additional calls to Commonwealth agency staff and key informants as needed to keep abreast of 
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demonstration developments. We will use site visit interviews to learn more about what factors 
are facilitating or impeding progress or leading to revisions in the Massachusetts demonstration 
implementation. 
Table 6 shows the types of demonstration implementation elements we will track using 
State submissions to the SDRS, quarterly calls with State demonstration staff, other interviews, 
and site visits.  
Table 6 
Implementation tracking elements by demonstration design feature  
Design feature Tracking elements 
Integrated delivery system ● Three-way contracts with One Care plans 
● Documentation of coordination activities between One Care plans 
and community-based organizations 
● New waiver authorities submitted for the demonstration and 
approved 
● Emergence of new medical homes and health homes 
● Strategies for integrating primary care, behavioral health, and LTSS 
(as documented in Commonwealth policies, contracts, or guidelines) 
● Recognition and payment for care/services by nontraditional workers 
● Innovative care delivery approaches adopted by the demonstration 
Integrated delivery system 
supports 
● Learning collaboratives of primary care providers 
● Support with dissemination and implementation of evidence-based 
practice guidelines (e.g., webinars for providers; topics addressed in 
learning collaboratives) 
● Decision-support tools provided or supported by the Commonwealth  
● Commonwealth efforts to build One Care plan and provider core 
competencies for serving beneficiaries with various types of 
disabilities 
● Provision of regular feedback to One Care plans and providers on the 
results of their performance measures 
Care coordination ● Adoption of person-centered care coordination practices 
● Commonwealth or plan systems for collecting data on care 
coordination use  
● As available, care coordination activities directed to individual 
enrollees 
● Commonwealth requirements for assessment and care planning 
● Commonwealth requirements for coordination and integration of 
clinical, LTSS, and behavioral health services  
● Commonwealth approaches to stratify care coordination intensity 
based on individual needs 
● Commonwealth-level analyses of enrollee care transitions 
● Commonwealth requirements for care transition support, medication 
reconciliation, notification of hospitalizations  
● Commonwealth actions to facilitate adoption of EMR and EHR  
● Use of informatics to identify high-risk beneficiaries 
 (continued) 
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Table 6 (continued) 
Tracking elements by demonstration design feature  
Design feature Tracking elements 
Benefits and services ● Phase-in of new or enhanced benefits, and methods to communicate 
them to enrollees and potential enrollees 
● Adoption of evidence-based practices and services (e.g., use of 
chronic disease self-management programs, fall prevention 
programs, other)  
Enrollment and access to care ● Commonwealth efforts to provide integrated consumer information 
on enrollment, benefits, and choice of One Care plan/providers 
● Options counseling and information provided by Aging and 
Disability Resource Centers and State Health Insurance Assistance 
Programs 
● Initiatives to increase enrollment in the demonstration  
● Strategies for expanding beneficiary access to demonstration benefits 
● Emergence of new worker categories/functions (e.g., health coaches, 
community care workers) 
Beneficiary engagement and 
protections 
● Strategies implemented to engage beneficiaries in oversight of the 
demonstration  
● Quality management strategy, roles, and responsibilities 
● Implementation of quality metrics 
● Adoption of new Commonwealth policies for beneficiary grievances 
and appeals based on demonstration experience 
Financing and payment ● Revisions to the demonstration’s initial payment methodology, 
including risk-adjustment methodology  
● Risk-mitigation strategies 
● Performance incentive approaches  
● Value-based purchasing strategies 
EHR = electronic health records; EMR = electronic medical records; LTSS = long-term services and 
supports; QIs = quality improvement initiatives. 
3.5 Progress Indicators 
In addition to tracking implementation of demonstration design features, we will also 
track progress indicators, including growth in enrollment and disenrollment patterns, based on 
Massachusetts demonstration data. These progress indicators will be reported quarterly by 
Massachusetts through the SDRS, which will be the evaluation team’s tool for collecting and 
storing information and for generating standardized tables and graphs for quarterly monitoring 
reports for CMS and the Commonwealth. The primary goals of the system are to serve as a 
repository for up-to-date information about the Massachusetts demonstration design and 
progress, to capture Commonwealth-specific data elements on a quarterly basis, and to monitor 
and report on demonstration progress by individual States and the demonstration as a whole. 
More detail on the SDRS can be found in the Aggregate Evaluation Plan (Walsh et al., 2013). 
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Table 7 presents a summary of progress indicators developed to date. The list of progress 
indicators may be refined in consultation with CMS as needed. RTI will provide trainings and an 
instruction manual to assist States in using the SDRS. 
Table 7 
Examples of progress indicators  
Indicator 
Eligibility 
No. of beneficiaries eligible to participate in the demonstration 
Enrollment 
Total no. of beneficiaries currently enrolled in the demonstration 
No. of beneficiaries newly enrolled in the demonstration as of the end of the given month 
No. of beneficiaries automatically (passively) enrolled in the demonstration 
Disenrollment 
No. of beneficiaries who opted out of the demonstration prior to enrollment 
No. of beneficiaries who voluntarily disenrolled from the demonstration 
No. of beneficiaries whose enrollment in the demonstration ended involuntarily (e.g., died, moved out of 
area, lost Medicaid eligibility, were incarcerated) 
Demonstration service area 
Whether demonstration is currently statewide vs. in specific counties or geographic areas (and provide list 
if in specific geographic areas) 
Self-direction of personal care services 
No. of enrollees in the demonstration who have chosen to self-direct their personal care services 
Specific to capitated model demonstrations 
No. of three-way contracts with One Care plans  
 
3.6 Data Sources 
The evaluation team will use a variety of data sources to assess whether the 
Massachusetts demonstration was implemented as planned; identify modifications made to the 
design features during implementation; document changes in the time frame or phase-in of key 
elements; and determine factors that facilitated implementation or presented challenges. These 
data sources include the following:  
• Commonwealth policies and Commonwealth requirements for provider and One 
Care plan agreements: The evaluation team will review a wide range of 
Commonwealth-developed documents that specify the Massachusetts approach to 
implementing its demonstration in order to develop a baseline profile of its current 
delivery system. Review of the Massachusetts agreements with CMS articulated 
through the demonstration Memorandum of Understanding (MOU), waivers, 
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contracts, and State Plan Amendments (if applicable) will further enhance our 
understanding of the Massachusetts approach.  
• Demonstration data (collected via the State Data Reporting System): On a 
quarterly basis, we will collect data from Massachusetts to inform ongoing analysis 
and feedback to the Commonwealth and CMS throughout the demonstration. 
Specifically, we will collect data to track policy and operational changes and progress 
indicators that are mostly numeric counts of key demonstration elements presented in 
Table 7. These demonstration data also may include specific information provided by 
CMS or other entities engaged in this demonstration, and incorporated into the State 
Data Reporting System. 
• Commonwealth agency staff, stakeholders, selected One Care plans/providers: 
There will be at least two sets of site visits; the first one will occur within 6 months of 
demonstration implementation. Using two-person teams, supplemented with 
telephone interviews, we will obtain perspectives from key informants on progress to 
date, internal and external environmental changes, reasons Massachusetts took a 
particular course, and current successes and challenges. In addition to the site visits, 
and interim calls for clarification about Commonwealth data submitted to the 
reporting system, in consultation with CMS we will develop a schedule of quarterly 
telephone interviews with various individuals involved in the demonstration. 
• In addition to consumer advocates, as discussed in Section 4.1, Beneficiary 
Experience, candidates for key informant interviews on demonstration 
implementation include the following:  
– Representatives from Implementation Council 
– Representatives from CMS–State Contract Management Team 
– State officials, such as: 
▪ Secretary of Executive Office of Health and Human Services 
▪ Medicaid director 
▪ Deputy Medicaid director for policy and programs 
▪ One Care plan program manager 
▪ Contract managers from the Contracted Customer Service and Integrated 
Contracting Unit 
▪ MassHealth finance managers 
▪ Commonwealth representatives from the Interagency Duals Steering 
Committee 
▪ Commonwealth agencies representing Medicare-Medicaid enrollees aged 21 
to 64, including the Department of Mental Health, Department of 
Developmental Services, MA Rehabilitation Commission, Executive Office of 
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Elder Affairs, MA Commission for the Deaf and Hard of Hearing, and the 
MA Commission for the Blind 
– Representatives from selected One Care plans 
– Representatives from providers and provider associations 
– Representatives from the SHINE Program (Serving the Health Information Needs 
of Everyone)  
– Representatives from the Medicare-Medicaid Ombuds program 
The site visit interview protocols used in the evaluation will contain a core set of 
questions that allow us to conduct an aggregate evaluation, questions specific to the financial 
alignment model (capitated), as well as a few questions that are specific to the Massachusetts 
demonstration. Questions tailored to the key informants in Massachusetts will be developed once 
the demonstration is implemented and will be provided to the Commonwealth in advance of the 
site visit. The site visit interview protocols with core questions are provided in the Aggregate 
Evaluation Plan (Walsh et al., 2013) and will also be tailored for Massachusetts. In advance of 
the site visits, the RTI team will contact the Commonwealth to determine the appropriate 
individuals to interview. We will work with the Commonwealth to schedule the site visit and the 
on-site interviews. We will develop an interview schedule that best suits the needs of the 
Commonwealth and key informants we plan to interview.  
3.7 Analytic Methods 
Evaluation of the Massachusetts demonstration implementation will be presented in an 
initial report to CMS and the Commonwealth covering the first 6 months of implementation, in 
annual State-specific evaluation reports, and integrated into annual aggregate reports comparing 
implementation issues and progress across similar demonstrations and across all demonstrations, 
as appropriate. We will collect and report quantitative data quarterly as noted in Table 7, 
Examples of Progress Indicators, through the State Data Reporting System. We will integrate 
these quantitative data with qualitative data we will collect through site visits and telephone 
interviews with Commonwealth agency staff and other key informants, and include these data in 
the annual reports and the final evaluation report. These data will provide context for interpreting 
the impact and outcomes related to beneficiary experience, quality, utilization, and costs, and 
enable us to analyze (1) the changes Massachusetts has made to the preexisting delivery systems 
serving Medicare-Medicaid enrollees; (2) challenges Massachusetts has met; and (3) approaches 
that can inform adaptation or replication by other States. 
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4. Impact and Outcomes 
4.1 Beneficiary Experience 
4.1.1 Overview and Purpose 
The evaluation will assess the impact of the Massachusetts demonstration on beneficiary 
experience. Using mixed methods (i.e., qualitative and quantitative approaches), we will monitor 
and evaluate the experience of beneficiaries, their families, and caregivers. Our methods will 
include the following: 
• the beneficiary voice through focus groups and stakeholder interviews conducted by 
RTI;  
• results of Consumer Assessment of Healthcare Providers and Systems (CAHPS) and 
any other surveys conducted by Massachusetts, CMS, or other entities;  
• Massachusetts demonstration data and data from other sources submitted via the State 
Data Reporting System (SDRS; e.g., data on enrollments, disenrollments, appeals, 
grievances, stakeholder engagement activities); 
• claims and encounter data obtained from CMS will be used to analyze utilization as 
well as access to services and outcomes for key quality measures; and  
• interviews with Massachusetts demonstration staff during site visit or telephone 
interviews with RTI. 
Table 8 (described in more detail below) shows the range of topics and data sources we 
will use to monitor and evaluate beneficiary experience. We are interested in the perspective of 
the beneficiaries themselves, determining specifically the impact of the demonstration on their 
access to needed services, the integration and coordination of services across settings and 
delivery systems, provider choice, enrollee rights and protections, and the provision of person-
centered care. In the process, we will identify what has changed for beneficiaries since their 
enrollment in the demonstration and its perceived impact on their health and well-being.  
This section of the evaluation plan focuses specifically on the methods we will use to 
monitor and evaluate beneficiary experience, such as focus groups with beneficiaries and 
interviews with consumer and advocacy groups. We also discuss information about data we will 
obtain from Massachusetts through interviews and the SDRS, and results of beneficiary surveys 
that may be administered and analyzed independent of this evaluation by the Commonwealth, 
CMS, or by other entities. 
Through beneficiary focus groups and key stakeholder interviews (i.e., consumer and 
advocacy group members), we also will explore whether we can identify specific demonstration 
features in Massachusetts that may influence replication in other States. We will also collect 
information from Commonwealth demonstration staff and CMS or other entities that reflects the 
beneficiaries’ experiences (e.g., grievances and appeals, disenrollment patterns) using RTI’s 
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State Data Reporting System. Section 3, Demonstration Implementation Evaluation, describes 
topics we will monitor and document through interviews with Massachusetts demonstration staff 
and document reviews, including consumer protections and other demonstration design features 
intended to enhance the beneficiary experience. Refer to Section 4.2 for a discussion of the use 
of claims and encounter data to establish baseline information about the beneficiaries eligible for 
the demonstration, and how we will use these data to inform our understanding of the impact of 
the Commonwealth’s demonstration on its access to care and health outcomes. 
Specifically, we will address the following research questions in this section: 
• What impact does the Massachusetts demonstration have on the beneficiary 
experience overall and for beneficiary subgroups? 
• What factors influence the beneficiary enrollment decision? 
• Do beneficiaries perceive improvements in their ability to find needed health 
services? 
• Do beneficiaries perceive improvements in their choice of care options, including 
self-direction? 
• Do beneficiaries perceive improvements in how care is delivered? 
• Do beneficiaries perceive improvements in their personal health outcomes?  
• Do beneficiaries perceive improvements in their quality of life? 
4.1.2 Approach  
This mixed-method evaluation will combine qualitative information from focus groups 
and key stakeholder interviews with quantitative data related to beneficiary experience derived 
from the RTI State Data Reporting System and findings from surveys that may be conducted 
independently by Massachusetts, CMS, or other entities (e.g., CAHPS). Qualitative data will be 
obtained directly from a beneficiary or beneficiary representative through focus groups and 
interviews. To avoid potential bias or conflict of interest, we will apply a narrow definition of 
“representative” to include only family members, advocates, or members of organizations or 
committees whose purpose is to represent the interest of beneficiaries and who are not service 
providers or do not serve in an oversight capacity for the initiative. Although no baseline 
qualitative data are available, beneficiaries will be asked about their experience before the 
demonstration and how it may have changed during the course of the demonstration. 
Our framework for evaluating beneficiary experience is influenced by work conducted by 
the Center for Health Care Strategies (CHCS), which identified essential elements of integration 
affecting beneficiary experience, including the care process and quality of life (Lind and Gore, 
2010). Its work is intended to guide the design of integrated care systems for Medicare-Medicaid 
enrollees and to do so in ways that strengthen the beneficiary experience in the areas defined in 
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Table 8 














agency staff on 
demonstration 
implementation 
Integrated delivery system  
Choice 
Beneficiaries have choice of medical, 
behavioral, and LTSS services. 
     
     
X X X X X 
Beneficiaries have choice of medical, 
behavioral, and LTSS providers within the 
network. 
X X X X X 
Beneficiaries have choice to self-direct their 
care. 
X X — X X 
Beneficiaries are empowered and supported to 
make informed decisions. 
X X — — — 
Provider network 
Beneficiaries report that providers are available 
to meet routine and specialized needs. 
     
X X X X — 
Beneficiaries report that LTSS and behavioral 
health are integrated into primary and specialty 
care delivery. 
X X — X — 
Beneficiary engagement 
Beneficiaries consistently and meaningfully 
have the option to participate in decisions 
relevant to their care. 
     
X X X X — 
There are ongoing opportunities for beneficiaries 
to be engaged in decisions about the design and 
implementation of the demonstration. 







onitoring, and Evaluation of State  
D
em
onstrations to Integrate C
are for D










ber 23, 2013 
26 
Table 8 (continued) 


















Beneficiaries can easily navigate the delivery 
system. 
     
X X — X — 
Reduced duplication of services 
Beneficiary burden is reduced through 
elimination of duplicative tests and procedures. 
     
— — — X — 
Enrollment and access to care 
Enrollment 
Beneficiaries have choices and assistance in  
understanding their enrollment options. 
     
     
X X — X X 
Beneficiaries report ease of disenrollment. X X — X — 
Rate of beneficiaries who opt out of enrolling 
into demonstration. 
— — — X — 
Rate of disenrollment from the demonstration, 
by reason. 
— — — X — 
Access to care 
Beneficiaries can access the full range of 
scheduled and urgent medical care, behavioral 
health services, and LTSS. 
     
X X — X — 
Beneficiaries report improved quality of life due 
to access to the full range of services. 
X X X — — 
Beneficiaries report that waiting times for 
routine and urgent primary and specialty care are 
reasonable. 
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Beneficiary health rating.  
     
— — X — — 
Quality of Life 
Days free from pain. 
     
— — X — — 
Beneficiaries get the social and emotional 
supports they need.  
— X X — — 
Beneficiaries report that they are satisfied with 
their life. 
— X X — — 
Cultural appropriateness 
Beneficiaries have access to multilingual and 
culturally sensitive providers. 
     
X X — X X 
Beneficiaries report that written and oral 
communications are easy to understand. 
X X — X — 
Delivery systems supports 
Data sharing and communication 
Information is available and used by 
beneficiaries to inform decisions. 
     
     
X X — — X 
Beneficiaries report that providers are 
knowledgeable about them and their care 
history. 
X X — X — 
Beneficiaries have adequate discharge and 
referral instructions. 
X X — X X 
Beneficiaries report that providers follow up 
after visits or discharge. 
X X — X — 
Beneficiaries understand their options to specify 
that personal health data not be shared. 







onitoring, and Evaluation of State  
D
em
onstrations to Integrate C
are for D










ber 23, 2013 
28 
Table 8 (continued) 


















Assessment of need 
Assessment process integrates/addresses health,  
behavioral health, and LTSS. 
     
     
X X — X X 
Medical providers actively participate in 
individual care planning. 
— X X — — 
Beneficiaries report active participation in the 
assessment process. 
X X — X — 
Person-centered care 
Care is planned and delivered in a manner 
reflecting a beneficiary’s unique strengths, 
challenges, goals, and preferences.  
     
X X — X — 
Beneficiaries report that care managers have the 
skills and qualifications to meet their needs 
— X X — — 
Beneficiaries report that providers listen 
attentively and are responsive to their concerns. 
X X X X — 
Coordination of care 
The system facilitates timely and appropriate 
referrals and transitions within and across 
services and settings. 
     
X X X X — 
Beneficiaries have supports and resources to 
assist them in accessing care and self-
management.  
X X — X — 
Beneficiaries report ease of transitions across 
providers and settings. 
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agency staff on 
demonstration 
implementation 
Family and caregiver involvement 
Beneficiaries have the option to include family 
and/or caregivers in care planning. 
     
X X — X — 
The family or caregiver’s skills, abilities, and 
comfort with involvement are taken into account 
in care planning and delivery.  
X X — X — 
Benefits and services 
Awareness of covered benefits 
Beneficiaries are aware of covered benefits.  
     
     
X X — X — 
Availability of enhanced benefits 
The demonstration covers important services to 
improve care outcomes that are not otherwise 
available through Medicaid or Medicare program. 
     
— — — X X 
Flexible benefits are available to meet the needs of 
beneficiaries. 
— — — X X 
Awareness of enhanced benefits 
Beneficiaries are aware of enhanced benefits and 
use them. 
     
X X — X — 
Beneficiary safeguards 
Beneficiary protections 
Beneficiaries understand their rights. 
     
     
X X — X — 
Beneficiaries are treated fairly, are informed of 
their choices, and have a strong and respected 
voice in decisions about their care and support 
services. 
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agency staff on 
demonstration 
implementation 
Complaints, grievances, and appeals 
Beneficiaries have easy access to fair, timely, and 
responsive processes when problems occur. 
     
X X — X — 
Number and type of beneficiary complaints, 
grievance, and appeals. 
— — — X — 
Advocacy/member services 
Beneficiaries get assistance in exercising their 
rights and protections. 
     
X X — X — 
Finance and payment 
Provider incentives 
Beneficiary experience is taken into account 
when awarding provider and plan incentives. 
     
     
X — — — X 
Rate of auto-assignment (if available). — — — X — 
Rate of change of PCP requests (if available). — — — X — 
— = no data for cell; HCBS = home and community-based services; LTSS = long-term services and supports; PCP = primary care provider.  
1 The evaluation team will recommend questions to add to surveys conducted by Massachusetts or CMS. 
2 Drawn from State Data Reporting System, RTI analysis of administrative data, Consumer Assessment of Healthcare Providers and Systems (CAHPS) or Health 
Outcomes Survey (HOS) results, or from other beneficiary surveys that may be conducted by the Commonwealth or other entities. 
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Table 8 aligns key elements identified in the CHCS framework with the demonstration 
design features described in Section 3, Demonstration Implementation Evaluation. We 
modified some elements of the CHCS framework to reflect that not all Medicare-Medicaid 
enrollees require intensive services as suggested by the original CHCS language used when 
describing comprehensive assessments and multidisciplinary care teams. For each key element, 
we identify the impact on beneficiary experience and detail the data sources that RTI will use to 
obtain the information.  
As shown in Table 8, we will solicit direct feedback from beneficiaries served through 
the demonstration to determine how closely their experience compares to the desired outcomes 
(improvements in personal health outcomes, quality of life, how beneficiaries seek care, choice 
of care options, and how care is delivered). We will include topics specific to the demonstration 
and supplement our understanding of direct beneficiary experience with key stakeholder 
interviews (e.g., consumer and advocacy groups), a review of enrollment and disenrollment, 
grievances and appeals, claims and encounter data analysis, and interviews with Massachusetts 
staff on demonstration implementation.  
Table 9 highlights some of the quantitative measures of beneficiary experience we will 
monitor and evaluate using demonstration statistics and claims or encounter data analysis. See 
Section 4.2 for a discussion of the quality, utilization, and access to care measures we plan to 
examine as part of the overall evaluation of impact of the Massachusetts demonstration on 
beneficiary outcomes, including for subpopulations. The draft focus group protocol and the draft 
stakeholder interview protocol are both discussed in this section and are available in the 
Aggregate Evaluation Plan (Walsh et al., 2013).  
We will analyze our findings by subpopulation. When we can recruit sufficient numbers 
of individuals from the subpopulations of interest to participate in the focus groups, we will also 
analyze our focus group findings about beneficiary experience to determine whether differences 
exist by subpopulation. 
Table 9 
Demonstration statistics on quality, utilization, and access to care measures 
of beneficiary experience 
Rate of auto-assignment to One Care plans (if available) 
Rate of disenrollment from the demonstration by reason1 
Rate of beneficiaries who opt out of enrolling into demonstration 
Number and type of beneficiary complaints, grievance, and appeals 
Use of preventive services1 
Nursing facility admissions and readmissions1 
Emergency room use1 
Hospital admission and readmission rates1 
Follow-up care after hospital discharge1 
1 See Section 4.2, for discussion of specific measures. 
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4.1.3 Data Sources 
We will rely on five major data sources to assess beneficiary experience as shown in 
Table 8. In this section, we describe our plan for using focus group and stakeholder interviews; 
results of beneficiary surveys planned by the Commonwealth, CMS, or other entities (e.g., 
CAHPS); the Commonwealth demonstration data entered into the State Data Reporting System; 
and interviews with Commonwealth demonstration staff. 
4.1.3.1 Focus Groups 
We will conduct four focus groups in Massachusetts to gain insight into how the initiative 
affects beneficiaries. To ensure that we capture the direct experience and observations of those 
served by the Massachusetts demonstration, focus groups will be limited to demonstration 
enrollees, their family members, and informal caregivers. Table 10 shows our current plan for 
the composition and number of focus groups.  
We are aware that Massachusetts has conducted its own focus groups during the 
planning/design phase of its initiative and may continue to do so during the demonstration 
period. We will use findings from the Commonwealth’s activities to inform the content of the 
guides we use in conducting the focus groups. Preliminary topics of the focus groups include 
beneficiaries’ understanding of the demonstration, rights, options, and choices (e.g., plan, 
primary care provider); reasons beneficiaries choose to enroll and disenroll; their benefits; 
concerns or problems encountered; experience with care coordination; and access to primary and 
specialty care. Timing for conducting the focus groups will be influenced by our assessment of 
whether there is more to be learned about the experience of beneficiaries shortly after initial 
enrollment into the Massachusetts demonstration versus their perceptions of its effectiveness 
later in the Massachusetts demonstration. If the latter, we will conduct focus groups at least 1 
year after implementation so that beneficiaries have had a substantial amount of experience with 
the demonstration. We will make the decision regarding timing of the focus groups in 
conjunction with CMS. 
Table 10 
Purpose and scope of Commonwealth focus groups 
Primary purpose To understand beneficiary experience with the demonstration and, where possible, to identify 
factors and design features contributing to their experience. 
Composition Each focus group includes 8–10 individuals who may be beneficiaries or family members or 
caregivers representing beneficiaries. These may include but are not limited to beneficiaries 
aged 21 to 64 with 
● developmental disabilities 
● severe and persistent mental illness 
● substance use disorders 
● long-term services and supports (LTSS) use 
● multiple chronic conditions 
● serious physical disabilities 
Number Four focus groups  
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We will recruit focus group participants from eligibility and enrollment files independent 
of input from the Commonwealth. In doing so, we will identify beneficiaries reflecting a range of 
eligibility, clinical, and demographic characteristics enrolled in the Massachusetts demonstration. 
Our subcontractor, the Henne Group, will use a structured approach for screening potential 
participants and obtaining their agreement to participate. If there appear to be high initial rates of 
opting out or disenrollment from the demonstration in Massachusetts, we will consider 
convening focus groups with beneficiaries who have chosen to opt out or disenroll, to understand 
their decisions. We will work closely with Massachusetts demonstration staff to make the 
process of recruiting focus group members as smooth as possible for beneficiaries, such as 
selecting an accessible site and ensuring transportation and any needed special accommodations 
and supports to allow for full participation. Focus group recruitment and all focus group 
arrangements will be conducted with an awareness of the subpopulations of concern in 
Massachusetts. We will investigate the prevalence of non-English–speaking beneficiaries in the 
eligible population, and determine whether to hold any of the focus groups in languages other 
than English. A preliminary focus group protocol is presented in the Aggregate Evaluation Plan 
(Walsh et al., 2013). The protocol may be modified based on final decisions about focus group 
composition, content, and our understanding of issues raised during implementation of the 
Massachusetts demonstration.  
4.1.3.2 Key Stakeholder Interviews 
Our evaluation team will conduct key stakeholder interviews (consumer and advocacy 
groups) in Massachusetts, either in person as part of a scheduled site visit or by telephone, with 
major beneficiary groups whose stakeholders are served by the Massachusetts demonstration. 
The purpose of these interviews will be to assess the level of beneficiary engagement and 
experience with the demonstration and its perceived impact on beneficiary outcomes. Although 
we will interview service providers as part of our implementation analyses, service provider 
perspectives will not be the source of information for assessing beneficiary experience.  
Table 11 identifies potential groups in Massachusetts whose representatives we may wish 
to interview and the overall purpose of the interview. We will finalize the list of key stakeholders 
following discussions with demonstration staff in Massachusetts, a review of events and issues 
raised during the development of the demonstration, and the composition of enrollment by 
subpopulations.  
A draft outline of the key stakeholder interview at baseline is presented in the Aggregate 
Evaluation Plan (Walsh et al., 2013). We will revise this draft as we obtain more information 
about the Massachusetts demonstration and the issues that arise during its planning/design phase 
and early implementation. 
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Table 11 
Preliminary subpopulations and scope of key stakeholder interviews 
Primary 
purpose 
Baseline: Assess understanding of and satisfaction with demonstration design; expectations for the 
demonstration; perceived concerns and opportunities. 
Throughout demonstration: Spot improvements and issues as they emerge and assess factors 
facilitating and impeding positive beneficiary experience.  
Final year: Assess extent to which expectations were met; major successes and challenges; 
lessons learned from beneficiary’s perspective. 
Subpopulations Interviews will be held with consumer and advocacy groups whose members are served by the 
Massachusetts demonstration. These may include the following: 
● Advocacy and consumer organizations representing the demonstration’s eligible 
populations 
● Advocacy and consumer organizations participating in the Massachusetts Medicaid 
Advisory Committee and its subcommittees 
● Beneficiaries and/or consumer organizations serving on the Implementation 
Council for the Massachusetts demonstration 
● Beneficiaries serving on One Care plan Consumer Advisory Committees 
● Beneficiary advocates 
Number and 
frequency 
Baseline: Up to eight telephone interviews within 6 months after implementation. 
Throughout demonstration: Up to eight telephone or in-person interviews in Massachusetts each 
year to be conducted with the same individuals each time, unless other stakeholders or topics of 
interest are identified.  
Final year: Up to eight telephone or in-person interviews. 
 
4.1.3.3 Beneficiary Surveys 
The RTI evaluation team will not directly administer any beneficiary surveys as part of 
the evaluation, and we are not requiring that States administer beneficiary surveys for purposes 
of the evaluation. We will include relevant findings from beneficiary surveys already being 
conducted for this demonstration by Massachusetts, CMS, or other entities. We understand that 
One Care plans will be required to conduct a beneficiary experience survey and a Quality of Life 
survey, although final decisions on the content of the beneficiary survey have not been made. We 
will recommend standard questions for inclusion in surveys across all Financial Alignment 
Demonstrations, such as quality of life measures. Should Massachusetts be amenable to 
including these questions in the surveys to be conducted by the One Care plans, we will 
participate in discussions with the Commonwealth and CMS (and other CMS contractors, as 
appropriate) regarding content and sampling issues. Topics on which we will recommend 
common questions across State demonstrations are shown in Table 8.  
As part of CMS requirements for capitated managed care plans, One Care plans will be 
required to conduct the Health Outcomes Survey (HOS) and CAHPS. The Medicare CAHPS and 
HOS surveys will be sampled at the One Care plan level, allowing cross-plan and aggregate 
comparisons, where appropriate.  
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4.1.3.4 Demonstration Data 
We will use data about the demonstration that we collect from Massachusetts during site 
visits, from reports and other materials developed by the Commonwealth, through the State Data 
Reporting System, and data obtained from CMS or other entities to assess the beneficiary 
experience. Data of particular interest include the following: 
• Complaint, appeal, and grievance data from CMS or other entities, as available.  
• Disenrollment and opt-out rates.  
• Information about waiting lists or lags in accessing services, which will provide 
useful indications of where the system lacks capacity, as a topic for discussion during 
site visits or focus groups. 
• Rate of change in primary care provider (PCP) assignment (if available). 
The above quantitative indirect measures will be collected for all Medicare-Medicaid 
enrollees served under the demonstration and will be analyzed by subpopulations. 
In addition, Massachusetts plans to monitor quality using a selection of national 
measures, CMS/Commonwealth-defined process measures, and Commonwealth-specified 
measures (Memorandum of Understanding [MOU], 2012, pp. 93–105). To the extent relevant, 
we will use findings from these State-specific metrics to augment our assessment of beneficiary 
experience and outcomes in Massachusetts.  
4.1.3.5 Interviews with Massachusetts Demonstration Staff 
In addition to key stakeholder interviews conducted with consumer and advocacy groups, 
we will address issues of beneficiary engagement and feedback during our interviews with 
Massachusetts demonstration staff. These interviews, described in Section 3, will provide 
another perspective on how Massachusetts communicates and works with beneficiaries during 
the design and implementation of its demonstration. 
4.1.4 Analytic Methods 
Our analysis will assess beneficiary experience and determine, where possible, how it is 
affected by financial model and demonstration design features. We also want to examine whether 
and how beneficiary experience varies by subpopulations. The Henne Group will audio-record 
all focus groups, subject to approval of the group members, and the audio-recordings will be 
transcribed. Key stakeholder interview and focus group transcripts will be imported and analyzed 
using QSR NVivo 9, qualitative data analysis software, to identify emergent themes and patterns 
regarding beneficiary experiences during the demonstration and issues related to the evaluation 
research questions. A structured approach to qualitative analysis in NVivo 9 will allow us to 
identify themes in Massachusetts and compare and contrast those themes by subpopulation 
within and across States. Because it is implementing a demonstration using the capitated 
financial alignment model, we are particularly interested in comparing the Massachusetts 
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findings with those of other States’ capitated model demonstrations and in determining whether 
particular design features in this State’s demonstration are likely to affect beneficiary experience.  
Most demonstration data will be collected and tracked through the State Data Reporting 
System and analyzed using descriptive statistics reported quarterly through that system. We will 
also request summary statistics and reports from Massachusetts on its beneficiary experience and 
Quality of Life surveys and others that may be required. Information from site visits and site-
reported data beyond those described specifically in this section also are expected to inform 
analysis of beneficiary experience research questions. The findings will be grouped into the 
beneficiary experience domains defined in Section 4.1.2.  
As noted, the Commonwealth has conducted focus groups prior to the demonstration, and 
further indications of predemonstration beneficiary experience may be available from other 
sources. The evaluation will not, however, have baseline data or comparison group results in this 
area. Results of beneficiary surveys, focus groups, and other approaches employed during the 
demonstration period will be presented in the annual and final evaluation reports along with 
available context to inform interpretation. 
4.2 Analyses of Quality, Utilization, Access to Care, and Cost 
4.2.1 Purpose 
This section of the report outlines the research design, data sources, analytic methods, 
and key outcome variables (quality, utilization, and cost measures) on which we will focus in 
evaluating the Massachusetts demonstration. These analyses will be conducted using secondary 
data, including Medicare and Medicaid claims and managed care encounter data. This section 
addresses the following research questions: 
• What impact does the Massachusetts demonstration have on utilization patterns in 
acute, long-term, and behavioral health services, overall and for beneficiary 
subgroups? 
• What impact does the Massachusetts demonstration have on health care quality 
overall and for beneficiary subgroups? 
• Does the Massachusetts demonstration change access to care for medical, behavioral 
health, long-term services and supports (LTSS) overall and for beneficiary 
subgroups? If so, how? 
• What impact does the Massachusetts demonstration have on cost and is there 
evidence of cost savings in the Commonwealth? How long did it take to observe cost 
savings in the Commonwealth? How were these savings achieved in the 
Commonwealth? 
In this section, we discuss our approach to identifying the eligible population for 
Massachusetts and for identifying comparison group beneficiaries. This section also describes 
the data sources, key analyses to be performed over the course of the demonstration, and the 
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quality measures that will inform the evaluation. RTI will use both descriptive and multivariate 
analyses to evaluate the Massachusetts demonstration. Results of descriptive analyses focusing 
on differences across years and important subgroups on key outcome variables will be included 
in the Massachusetts quarterly reports to CMS and the Commonwealth and annual reports. 
Multivariate analyses of each year of demonstration data will be included in the final evaluation. 
Savings will be calculated at least twice during the demonstration period: once during the 
demonstration and once after the end of the demonstration.  
4.2.2 Approach  
An appropriate research design for the evaluation must consider whether selection is a 
risk for bias. Potential sources of selection bias exist in the Massachusetts demonstration 
whereby the beneficiaries choosing not to enroll in the demonstration may differ from 
demonstration participants. First, beneficiaries may choose to opt out or disenroll from the 
demonstration. Reasons for opting out or disenrolling will vary but may be related to 
demonstration benefits or previous experience in a One Care plan. Second, beneficiaries already 
enrolled in a Medicare Advantage plan or Program of All Inclusive Care for the Elderly (PACE) 
will not be eligible for passive enrollment into the demonstration, but can choose to disenroll 
from their current plans. To limit selection bias in the evaluation of this demonstration, we will 
use an intent-to-treat design. This design will address potential selection bias issues by including 
the entire population of beneficiaries eligible for the Massachusetts demonstration, regardless of 
whether they enroll in a One Care plan or actively participate in the care model.  
Under the intent-to-treat framework, outcome analyses will include all beneficiaries 
eligible for the demonstration in the demonstration States, including those who opt out, 
participate but then disenroll, are eligible but are not contacted by the State or participating 
providers, and those who enroll but do not engage with the care model, and a group of similar 
individuals in the comparison group. This approach diminishes the potential for selection bias 
and highlights the effect of the demonstrations on all beneficiaries in the demonstration-eligible 
population. In addition, RTI will compare the characteristics of those who enroll with those who 
are eligible but do not enroll in the care model and conduct analyses to further explore 
demonstration effects on demonstration enrollees, acknowledging that interpreting such results 
will be difficult given likely selection bias. 
4.2.2.1 Identifying Demonstration Group Members 
The demonstration group for Massachusetts will include full-benefit Medicare-Medicaid 
enrollees aged 21 to 64 years old, including individuals with severe and persistent mental illness, 
drug dependence, substance use disorders, and chronic physical conditions. To analyze quality, 
utilization, and costs in the predemonstration period, and throughout the demonstration period, 
Massachusetts will submit a demonstration evaluation (finder) file that includes data elements 
needed for RTI to correctly identify Medicare-Medicaid enrollees for linking to Medicare and 
Medicaid data, and information about whether the enrollees were eligible for or enrolled in a 
Financial Alignment Demonstration (Table 12). The file will list all of the Medicare-Medicaid 
eligible population for the demonstration, with additional variables in the file indicating monthly 
participation in the demonstration. Eligible individuals who were not enrolled in the 
demonstration in a given month will still be part of the evaluation under the intent-to-treat 
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research design. In addition to indicating who was eligible and enrolled, this file will contain 
personal identifying information for linking to Medicare and Medicaid data. RTI will notify the 
State about the file's design and the method and timing of transmission after the start of the 
demonstration. 
Table 12 
State demonstration evaluation (finder) file data fields 






11 CHAR Alphanumeric The HICN. Any Railroad Retirement Board 
(RRB) numbers should be converted to the 
HICN number prior to submission to the 
MDM. 
MSIS number 20 CHAR Alphanumeric MSIS identification number. 
Social security number 
(SSN) 
9 CHAR Numeric Individual's SSN.  
Sex 1 CHAR Alphanumeric Sex of beneficiary (1=male or 2=female). 
Person first name 30 CHAR Alphanumeric The first name or given name of the 
beneficiary. 
Person last name 40 CHAR Alphanumeric The last name or surname of the beneficiary. 
Person birth date 8 CHAR CCYYMMDD The date of birth (DOB) of the beneficiary. 
Person ZIP code 9 CHAR Numeric 9-digit ZIP code.  
Eligibility 
identification flag  
1 CHAR Numeric Coded 0 if identified as not eligible for the 
demonstration, 1 if identified as eligible from 
administrative data, 2 if identified as eligible 
from nonadministrative data.  
Monthly enrollment 
indicator 
1 CHAR Numeric Each monthly enrollment flag variable would 
be coded 1 if enrolled, and zero if not. 
Quarterly demonstration evaluation (finder) 
files would have 3 such data fields; annual 
demonstration evaluation (finder) files would 
have 12 such data fields. 
MDM = Master Data Management; MSIS = Medicaid Statistical Information System. 
4.2.2.2 Identifying a Comparison Group  
The methodology described in this section reflects the plan for identifying comparison 
groups based on discussions between RTI and CMS and detailed in the Aggregate Evaluation 
Plan (Walsh et al., 2013). Identifying the comparison group members will entail two steps: 
(1) selecting the geographic area from which the comparison group will be drawn and 
(2) identifying the individuals who will be included in the comparison group. 
Because most Massachusetts counties and demonstration-eligible beneficiaries will be 
included in the demonstration area, we will most likely consider a comparison group from out-
of-State Metropolitan Statistical Areas (MSAs). In general, we expect to draw out-of-State 
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comparison groups from multiple comparison States and areas. However, if for any reason the 
Massachusetts demonstration is not implemented statewide, we will determine whether there are 
areas within Massachusetts that could also be part of the comparison group. The approach for 
identifying in-State comparison areas would be the same as the process for identifying an out-of-
State comparison group, described below.  
We will use statistical distance analysis to identify potential comparison areas that are 
most similar to Massachusetts in regard to costs, care delivery arrangements, and policy affecting 
Medicare-Medicaid enrollees. The specific measures for the statistical distance analysis we will 
use are Medicare spending per Medicare-Medicaid enrollee, Medicaid spending per Medicare-
Medicaid enrollee, nursing facility users per 65-and-over Medicaid enrollee, home and 
community-based (HCBS) users per 65-and-over Medicaid enrollee, Personal Care users per 65-
and-over Medicaid enrollee, Medicare Advantage penetration, and Medicaid managed care 
penetration for full-benefit Medicare-Medicaid enrollees. The three LTSS variables capture how 
areas differ in the settings in which they provide these services. Variation in LTSS policy is most 
easily visible in the population using the most LTSS (i.e., those aged 65 and over). The relative 
importance of institutional care observed in that population is expected to affect such use in the 
population under age 65 as well. 
Once comparison areas are selected, all Medicare-Medicaid enrollees in those States who 
meet the demonstration’s eligibility criteria will be selected for comparison group membership 
based on the intent-to-treat study design. The comparison areas will be determined within the 
first year of demonstration implementation, in order to use the timeliest data available. The 
comparison group members will be determined retrospectively at the end of each demonstration 
year, allowing us to include information on individuals newly eligible or ineligible for the 
demonstration during that year. The comparison group will be refreshed annually to incorporate 
new entrants into the eligible population as new individuals become eligible for the 
demonstration over time. To ensure that the comparison group is similar to the demonstration 
group, we will compute propensity scores and weight comparison group beneficiaries using the 
framework described in Section 4.2.2.4 of this report. 
4.2.2.3 Issues/Challenges in Identifying Comparison Groups 
The RTI team will make every effort to account for the following four issues/challenges 
when identifying and creating comparison groups.  
1. Similarities between demonstration and comparison groups: Comparison group 
members are as much like demonstration group members as possible and sufficient 
data are needed to identify and control for differences.  
2. Sample size: Given that the team plans to use all comparable beneficiaries in an out-
of-State comparison group that would be eligible for the demonstration, we expect to 
have sufficient sample size for the statewide analyses and for analyses of smaller 
subpopulations. 
3. Accounting for enrollment in other demonstrations: Some Medicare-Medicaid 
enrollees may not be suitable for comparison group selection because of participation 
in other demonstrations or enrollment in Accountable Care Organizations. We will 
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work with CMS to specify these parameters and apply them to both Massachusetts 
and the comparison group.  
4. Medicaid data: Significant time delays currently exist in obtaining Medicaid data. If 
unaddressed, this could result in delays in formulating appropriate comparison 
groups. Timeliness of Medicaid Statistical Information System (MSIS) data 
submissions will need to be considered if out-of-State comparison areas are required 
for the evaluation. 
4.2.2.4 Propensity Score Framework for Identifying Comparison Group Members 
Because comparison group members may differ from the demonstration group on 
individual characteristics, we will compute propensity scores for the demonstration and 
comparison group members. The propensity score represents how well a combination of 
characteristics, or covariates, predicts that a beneficiary is in the demonstration group. To 
compute these scores for beneficiaries in the demonstration and comparison groups, we will first 
identify beneficiary- and market-level characteristics to serve as covariates in the propensity-
score model. Beneficiary-level characteristics may include demographics, socioeconomic, health, 
and disability status, and county-level characteristics may include health care market and local 
economic characteristics. Once the scores are computed, we will remove from the comparison 
group any beneficiaries with a propensity score lower than the lowest score found in the 
demonstration group to ensure that the comparison group is similar to the demonstration group. 
The propensity scores for the comparison group will then be weighted so that the 
distribution of characteristics of the comparison group is similar to that of the demonstration 
group. By weighting comparison group members’ propensity scores, the demonstration and 
comparison group samples will be more balanced. More detail on this process is provided in the 
Aggregate Evaluation Plan (Walsh et al., 2013).  
4.2.3 Data Sources 
Table 13 provides an overview of the data sources to be used in the Massachusetts 
evaluation of quality, utilization, and cost. Data sources include Medicare and Medicaid fee-for-
service data, Medicare Advantage encounter data, and Medicare-Medicaid Plan encounter data. 
These data will be used to examine quality, utilization, and cost in the predemonstration period 
and during the demonstration. Data will be needed for all beneficiaries enrolled in the 
demonstration as well as other beneficiaries in the eligible population who do not enroll. Note 
that data requirements for an individual beneficiary will depend on whether they were in 
Medicare fee-for-service or Medicare Advantage in the pre- and postdemonstration periods.  
The terms of the Massachusetts MOU require the Commonwealth to provide timely 
Medicaid data through MSIS submissions for the predemonstration and demonstration periods. 
Any delays in obtaining data may also delay portions of the evaluation. 
The activities to identify demonstration and comparison groups and to collect and utilize 
claims and encounter data may be revised if modifications are made to the demonstrations or if 
data sources are not available as anticipated. If modifications to this evaluation plan are required, 
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Data sources to be used in Massachusetts Financial Alignment Demonstration evaluation analyses of quality, utilization, 
and cost  
Aspect  Medicare fee-for-service data Medicaid fee-for-service data Encounter data1 
Obtained from CMS CMS CMS 
Description and uses 
of data 
Will be pulled from 
● Part A (hospitalizations) and 
● Part B (medical services). 
Will be used to evaluate quality of care, 
utilization, and cost during the 
demonstration. These data will also be 
used for beneficiaries who opt out of 
the demonstration, have disenrolled, or 
do not enroll for other reasons; for 
predemonstration analyses of 
demonstration-eligible beneficiaries for 
the 2 years prior to the demonstration; 
and for comparison groups that may be 
in-state or out-of state. 
Medicaid claims and enrollment data will 
include data on patient characteristics, 
beneficiary utilization, and cost of services. 
Eligibility files will be used to examine 
changes in number and composition of 
Medicare-Medicaid enrollees. Will also 
need these data for beneficiaries who opt 
out of the demonstration, have disenrolled, 
or do not enroll for other reasons; for 
predemonstration analyses of 
demonstration-eligible beneficiaries for the 
2 years prior to the demonstration; and for 
comparison groups.  
Pre- and postperiod beneficiary encounter data 
(including Medicare Advantage, and Medicare-
Medicaid Plan, and Part D data) will contain 
information on 
● beneficiary characteristics and diagnoses, 
● provider identification/type of visit, and 
● beneficiary IDs (to link to Medicare and 
Medicaid data files). 
Will be used to evaluate quality (readmissions), 
utilization, and cost; health; access to care; and 
beneficiary satisfaction. Part D data will be used 
to evaluate cost only. These data will also be used 
for beneficiaries who opt out of the 
demonstration, have disenrolled, or do not enroll 
for other reasons; for predemonstration analyses 
of demonstration-eligible beneficiaries for the 2 
years prior to the demonstration; and for 
comparison groups that may be in-state or out-of 
state. 
Sources of data Will be pulled from the following: 
● NCH Standard Analytic File  
● NCH TAP Files 
● Medicare enrollment data 
Will be pulled from the following: 
● MSIS (file on inpatient care, 
institutional, and the “other” file) 
● Medicaid eligibility files 
Data will be collected from the following: 
● CMS  
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Table 13 (continued) 
Data sources to be used in Massachusetts Financial Alignment Demonstration evaluation analyses of quality, utilization, 
and cost  
Aspect Medicare fee-for-service data Medicaid fee-for-service data Encounter data1 
Time frame of data Baseline file = 2 years prior to the 
demonstration period (NCH Standard 
Analytic File). 
Evaluation file = all demonstration 
years (NCH TAP Files). 
Baseline file = 2 years prior to the 
demonstration period. 
Evaluation file = all demonstration years. 
Baseline file = Medicare Advantage plans submit 
encounter data to CMS as of January 1, 2012. 
RTI will determine to what extent these data can 
be used in the baseline file. 
Evaluation file = Medicare Advantage and One 
Care plans are required to submit encounter data 
to CMS for all demonstration years.  
Potential concerns — Expect significant time delay for all Medicaid 
data. 
CMS will provide the project team with data 
under new Medicare Advantage requirements. 
Any lags in data availability are unknown at this 
time. 
— = no data; MSIS = Medicaid Statistical Information System; NCH = National Claims History; TAP = monthly Medicare claims files. 
1 Encounter data from Medicare Advantage (MA) or PACE plans in the pre-period are needed to evaluate demonstration effects for beneficiaries who previously 
were enrolled in Medicare Advantage or PACE plans but who enroll in the demonstration. There may also be movement between Medicare Advantage or PACE 
plans and the demonstration throughout implementation, which we will need to take into account using Medicare Advantage or PACE encounter data during the 
implementation period. 
Notes on Data Access: CMS data contain individually identifiable data that are protected under the Health Insurance Portability and Accountability Act (HIPAA) 
of 1996. CMS, however, makes data available for certain research purposes provided that specified criteria are met. RTI has obtained the necessary Data Use 
Agreement (DUA) with CMS to use CMS data. A listing of required documentation for requesting CMS identifiable data files such as Medicare and MSIS is 
provided at http://www.resdac.umn.edu/medicare/requesting_data.asp.  
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4.3 Analyses 
The analyses of quality, utilization, and cost in the Massachusetts evaluation will consist 
of the following: 
1. a monitoring analysis to track quarterly changes in selected quality, utilization, and 
cost measures over the course of the Massachusetts demonstration (as data are 
available);  
2. a descriptive analysis of quality, utilization, and cost measures for annual reports 
with means and comparisons for subgroups of interest, including comparison group 
results; and  
3. multivariate difference-in-differences analyses of quality, utilization, and cost 
measures using an in-State or out-of-State comparison group, depending on whether 
the demonstration is implemented statewide.  
At least one multivariate regression-based savings analysis will be calculated during the 
demonstration period, most likely using 2 years of demonstration data. A second savings analysis 
will be included in the final evaluation.  
The approach to each of these analyses is outlined below in Table 14.  
Table 14 
Quantitative analyses to be performed for Massachusetts demonstration 
Aspect Monitoring analysis Descriptive analysis Multivariate analyses 
Purpose Track quarterly changes in 
selected quality, utilization, and 
cost measures over the course of 
the demonstration. 
Provide estimates of quality, 
utilization, and cost measures on 
an annual basis. 
Measure changes in quality, 
utilization, and cost measures 




Comparison of current value and 
values over time to the baseline 
period for each outcome. 
Comparison of the baseline 
period with each demonstration 
year for demonstration and 
comparison groups. 
Difference-in-differences 
analyses using demonstration 
and comparison groups.  
Reporting 
frequency 
Quarterly to CMS and the 
Commonwealth 
Annually Once, in the final evaluation 
except for costs, which will 
also be calculated (at least) 
once prior to the final 
evaluation. 
NOTE: The reports to be submitted to CMS will include the qualitative data described earlier in this report in 
addition to the quantitative data outlined here. 
4.3.1 Monitoring Analysis  
Data from Medicare fee for service (FFS) and Medicare Advantage encounter data, One 
Care plan encounter data, MSIS files, and other data provided by Massachusetts via the State 
Data Reporting System will be analyzed quarterly to calculate means, counts, and proportions on 
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selected quality, utilization, and cost measures common across States, depending on availability. 
Examples of measures that may be included in these quarterly reports to CMS include rates of 
inpatient admissions, emergency room visits, long-term nursing facility admissions, cost per 
member per month, and all-cause hospital readmission and mortality. We will present the current 
value for each quarter and the predemonstration period value for each outcome to look at trends 
over time. 
The goal of these analyses is to monitor and track changes in quality, utilization, and 
costs. Though quarterly analyses will not be multivariate or include comparison group data, these 
monitoring data will provide valuable, ongoing information on trends occurring during the 
demonstration period. Various inpatient and emergency room measures that can be reported are 
described in more detail in the section on quality measures. 
4.3.2 Descriptive Analysis on Quality, Utilization, and Cost Measures  
We will conduct a descriptive analysis of quality, utilization, and cost measures for the 
Massachusetts demonstration annually for each performance period that includes means, counts, 
and proportions for the demonstration and comparison groups. This analysis will focus on 
estimates for a broad range of quality, utilization, and cost measures, as well as changes in these 
measures across years or subgroups of interest within each year. The results of these analyses 
will be presented in the annual evaluation reports. The sections below outline the measures that 
will be included. 
To perform this analysis, we will develop separate (unlinked) encounter, Medicare, and 
Medicaid beneficiary-level analytic files annually to measure quality, utilization, and cost. 
Although the Medicare, Medicaid, and encounter data will not be linked, the unlinked 
beneficiary-level files will still allow for an understanding of trends in quality, utilization, and 
cost measures. The analytic files will include data from the predemonstration period and for each 
demonstration year. Because of the longer expected time lags in the availability of Medicaid 
data, Medicare fee-for-service data and One Care plan encounter data may be available sooner 
than Medicaid fee-for-service data. Therefore, we expect that the first annual report will include 
predemonstration Medicare and Medicaid fee-for-service data and Medicare fee-for-service, 
Medicare Advantage, and One Care plan encounter data for the demonstration period. Medicaid 
fee-for-service data will be incorporated into later reports as the data become available. 
Consistent with the intent-to-treat approach, all individuals eligible to participate in the 
demonstration will be included in the analysis, regardless of whether they opt out of the 
demonstration or disenroll, or actively engage in the care model. Data will be developed for 
demonstration and comparison group beneficiaries for a 2-year predemonstration period and for 
each of the years of the demonstration. The starting date for Massachusetts will be based on the 
Commonwealth’s implementation date and, therefore, may represent a “performance period,” not 
necessarily a calendar year. Because the Commonwealth plans to phase in enrollment first for 
those who actively select a One Care plan and later for those who are passively enrolled, 
enrollment for those who are passively enrolled later in the year will be identified by setting a 
dummy variable flag so that the analysis can determine whether the experience of those who 
passively enroll differs from that of those who actively enroll. For those beneficiaries with 
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shorter enrollment periods, because of beneficiary death or change of residence, for example, the 
analysis will weight their experience by months of enrollment within a performance period. 
We will measure predemonstration and annual utilization rates and costs of Medicare- 
and Medicaid-covered services together, where appropriate, to look at trends in the type and 
level of service use during the State demonstrations. We will calculate average use rates for each 
demonstration period. Use rates will be stratified by hierarchical condition category (HCC) 
scores, which are derived from models predicting annual Medicare spending based on claim-
based diagnoses in a prior year of claims where higher scores are predictive of higher spending, 
health status measures, or similar measures. We will adjust for hospitalizations in the prior year 
using categorical HCC scores or similar. Chi-square and t-tests will be used to test for significant 
differences in use across years and between subpopulations such as Medicare-Medicaid enrollees 
using behavioral health services and those referred for long-term care services.  
4.3.3 Multivariate Analyses of Quality, Utilization, and Cost Measures  
In the final year of the evaluation, we will use data collected for the eligible population in 
Massachusetts and data for the selected comparison group that will have been adjusted using 
propensity-score weighting methods to analyze the effect of the demonstration using a 
difference-in-differences method. This method uses both pre- and postperiod data for both the 
demonstration and comparison groups to estimate effects. This method will be applied to these 
data for each quality, utilization, and cost outcome described in the next section for the final 
evaluation. The analytic approaches are described in greater detail in the Aggregate Evaluation 
Plan (Walsh et al., 2013). In addition, multivariate regression-adjusted estimates of cost effects 
(only) will be performed at an intermediate point of the evaluation, using data after 2 years of 
implementation.  
4.3.4 Subpopulation Analyses 
Specific to the Massachusetts demonstration model, individuals with End Stage Renal 
Disease (ESRD), people receiving behavioral health services, and people receiving long-term 
services and supports (including individuals with developmental disabilities in the community 
not receiving waiver services) are subpopulations of interest for this evaluation. Individuals with 
chronic physical conditions, which the Commonwealth estimates to be about 40 percent of the 
eligible population, are another major subpopulation for the demonstration evaluation. Other 
subpopulations of potential interest to the evaluation may be identified to correspond to rating 
categories for payments to One Care plans for people (1) with facility-based care; (2) high 
community needs based on activities of daily living (ADL) needs, as determined from a 
Minimum Data Set-Home Care (MDS-HC) assessment, if data are available electronically; or 
(3) community high behavioral health needs. RTI will compare the characteristics of those who 
enroll with those who are eligible but do not enroll in the care model and conduct analyses to 
further explore demonstration effects on demonstration enrollees, acknowledging that selection 
bias must be taken into account in interpreting the results. 
For these subpopulations and others, RTI will evaluate the impact of the demonstration 
on quality, utilization, and access to care for medical, LTSS, and behavioral health services, and 
also examine qualitative data gathered through interviews, focus groups, and surveys. 
Descriptive analyses for annual reports will present results on selected measures stratified by 
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subpopulations (e.g., those using and not using behavioral health services, LTSS). Multivariate 
analyses performed for the final evaluation will account for differential effects for 
subpopulations in specification testing by using dummy variables for each of the specific 
subpopulations of interest one at a time so that the analyses can suggest whether quality, 
utilization, and cost are higher or lower for each of these groups. 
4.4 Utilization and Access to Care 
Medicare, Medicaid, and One Care plan encounter data will be used to evaluate changes 
in the levels and types of services used, ranging along a continuum from institutional care to care 
provided at home (Table 15). In addition to the services shown in Table 15, the Massachusetts 
analysis will include a specific focus on mental health and substance use disorder prevention and 
treatment services and community support services that will be expanded under the 
demonstration. Expanded services that will be available in the Massachusetts demonstration that 
may be tracked over time include dental, vision, and nonmedical transportation. As noted, two 
services (but not the people receiving them) are excluded from the Massachusetts demonstration: 
Department of Mental Health (DMH)– and Department of Developmental Services (DDS)–
provided targeted case management services, and DMH-purchased Rehabilitation Option 
services. Note that Table 15 indicates the sources of data for these analyses during the 
demonstration, given that the analyses will include beneficiaries who enroll in the demonstration 
as well as those who are part of the population eligible for the demonstration, but do not enroll in 
the demonstration. 
Table 15 











Inpatient X — X 
Emergency room X — X 
Nursing facility (short rehabilitation stay) X — X 
Nursing facility (long-term stay) X X — 
Other facility-based1 X — X 
Outpatient2 X — X 
Outpatient behavioral health (mental and 
substance use) 
X X — 
Home health X — X 
HCBS (PAS, waiver services) X X — 
Dental X X — 
— = not available; FFS = fee for service; HCBS = home and community-based services; MCO = managed care 
organization; PAS = personal assistance services. 
1 Includes long-term care hospital, rehabilitation hospital, State mental health facility stays. 
2 Includes visits to physician offices, hospital outpatient departments, rehabilitation agencies. 
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We anticipate being able to develop traditional utilization measures for each of the 
service classes in Table 15 (e.g., various inpatient use rates based on diagnoses of interest); 
however, as of this writing, the data that demonstration One Care plans will be required to 
submit have not been finalized.  
4.5 Quality of Care  
Across all States, we will evaluate a core quality measure set for monitoring and 
evaluation purposes. There are multiple data sources for quality measures: claims and encounter 
data, which will be obtained and analyzed by the RTI team for evaluation measures listed in 
Table 16; and information collected by the Commonwealth, CMS, or others and provided in 
aggregate to the RTI team for inclusion in reports. The latter may include Health Care 
Effectiveness Data and Information Set (HEDIS) measures collected as part of health plan 
performance, other data Massachusetts requires its One Care plans to report, and any beneficiary 
survey data collected by Massachusetts, CMS, or other entities (e.g., CAHPS). CMS and 
Massachusetts have also identified a set of quality measures that will determine the amount of 
quality withhold payments (i.e., One Care plans must meet quality standards to earn back a 
withheld portion of their capitated payments). The quality withhold measures, listed in the 
Massachusetts MOU, include some measures noted in this report, as well as additional measures. 
RTI expects to have access to the aggregated results of these additional measures and will 
include them in the evaluation as feasible and appropriate, understanding that these data are not 
available for the pre-demonstration period or for the comparison group.  
RTI and CMS have developed the core set of evaluation measures for use across State 
demonstrations; the evaluation will also include a few measures specific to Massachusetts. 
Table 16 provides a working list of the core quality measures for the evaluation of the financial 
alignment initiative. The table specifies the measure, the source of data for the measure, whether 
the measure is intended to produce impact estimates, as well as a more detailed definition and 
specification of the numerator and denominator for the measure. These measures will be 
supplemented by additional evaluation measures appropriate to the Massachusetts demonstration. 
We will finalize State-specific quality measures within the first 6 months of implementation, 
Many of the measures in Table 16 are established HEDIS measures that demonstration 
plans are required to report. The National Committee for Quality Assurance (NCQA) definitions 
are established and standardized. Given that these data will not be available for those who opt 
out or disenroll or for comparison populations, we will collect and present the results for each 
relevant demonstration period. 
The unique features of Massachusetts’s planned demonstration suggest areas of special 
focus in quality of care analyses. Notably, the new One Care plans will serve only those aged 21 
to 64 at the time of enrollment (allowing those who turn 65 after enrollment to remain in the 
demonstration). We have considered the value of collecting quality measures that have been 
developed specifically for the over-65 population in the context of the younger age groups 
eligible for the Massachusetts demonstration. We have decided to include measures such as 
medication reconciliation and pneumonia vaccination, though they were developed for the over-
65 population. In the case of pneumonia vaccine, for example, the Centers for Disease Control 
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and Prevention (CDC) has recommended that those aged 2 to 64 receive the vaccine if they have 
long-term health problems. 
Our analyses will pay particular attention to the types of care with the most change. The 
Massachusetts demonstration plans to change the behavioral health system for enrollees by 
making available a wide array of new services aimed at reducing the rate of acute psychiatric 
hospitalization through the use of “diversionary” services. Thus, although the generic measures 
of quality include all-cause readmission rates, and ambulatory care sensitive conditions (ACSC) 
hospitalization rates, our evaluation of the Massachusetts demonstration will also examine rates 
of hospitalization with primary diagnosis of a severe and persistent mental illness or substance 
use disorder. Another measure of relevance to Massachusetts given the increase in mental health 
benefits during the demonstration may be a National Quality Forum (NQF) measure of initiation 
and engagement of alcohol and other drug dependence treatment. This measure looks at the 
initiation of treatment and subsequent service use within 30 days of initiating treatment and can 
be calculated using claims and encounter data. 
Finally, the evaluation will analyze subgroups of interest, as appropriate, and look at 
measures that might be particularly relevant to them (e.g., measures that might be specific to 
people with developmental disabilities, behavioral health conditions). We will continue to work 
with CMS and the Commonwealth to identify measures relevant to Massachusetts and will work 
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Table 16 

























readmission rate  
Claims/encounter 




Yes Risk-adjusted percentage of demonstration- 
eligible Medicare-Medicaid enrollees who 
were readmitted to a hospital within 30 days 




Numerator: Risk-adjusted readmissions among 
demonstration-eligible Medicare-Medicaid enrollees 
at a non-Federal, short-stay, acute-care or critical 
access hospital, within 30 days of discharge from the 
index admission included in the denominator, and 
excluding planned readmissions.  
Denominator: All hospitalizations among 
demonstration-eligible Medicare-Medicaid enrollees 
not related to medical treatment of cancer, primary 
psychiatric disease, or rehabilitation care, fitting of 
prostheses, and adjustment devices for beneficiaries 
at non-Federal, short-stay acute-care or critical 
access hospitals, where the beneficiary was 
continuously enrolled in Medicare and Medicaid for 
at least 1 month after discharge, was not discharged 
to another acute-care hospital, was not discharged 
against medical advice, and was alive upon 





RTI will acquire 
and analyze 
Prevention Yes Percentage of demonstration-eligible 
Medicare-Medicaid enrollees seen for a visit 
between October 1 and March 31 of the 1-
year measurement period who received an 
influenza immunization OR who reported 




Medicaid enrollees who have received an influenza 
immunization OR who reported previous receipt of 
influenza immunization.  
Denominator: Demonstration-eligible Medicare-
Medicaid enrollees seen for a visit between October 
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Table 16 (continued) 

























patients under age 
65 
Claims/encounter 
RTI will acquire 
and analyze 
Prevention Yes Percentage of demonstration-eligible 
patients under age 65who have ever 
received a pneumococcal vaccine. 
Numerator: Demonstration-eligible Medicare-Medicaid 
enrollees under age 65who have ever received a 
pneumococcal vaccination.  
Denominator: All demonstration-eligible Medicare-
Medicaid enrollees under age 65, excluding those with 








(AHRQ PQI # 90) 
Claims/encounter 




Yes Combination using 12 individual ACSC 
diagnoses for chronic and acute 
conditions. For technical specifications of 
each diagnosis, see 
http://www.qualityindicators.ahrq.gov/M
odules/PQI_TechSpec.aspx. 
Numerator: Total number of acute-care hospitalizations 
for 12 ambulatory care-sensitive conditions among 
demonstration-eligible Medicare-Medicaid enrollees, 
aged 18 or older. Conditions include diabetes—short-
term complications; diabetes—long-term 
complications; COPD; hypertension; CHF; 
dehydration; bacterial pneumonia; UTI; angina without 
procedure; uncontrolled diabetes; adult asthma; lower 
extremity amputations among diabetics.  
Denominator: Demonstration-eligible Medicare-





(AHRQ PQI # 92) 
Claims/encounter 




Yes Combination using 9 individual ACSC 
diagnoses for chronic diseases. For 




Numerator: Total number of acute-care hospitalizations 
for 9 ambulatory care sensitive chronic conditions 
among demonstration-eligible Medicare-Medicaid 
enrollees, aged 18 or older. Conditions include 
diabetes—short-term complications; diabetes—long-
term complications; COPD; hypertension; CHF; angina 
w/o procedure; uncontrolled diabetes; adult asthma; 
lower-extremity amputations among diabetics).  
Denominator: demonstration-eligible Medicare-
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Table 16 (continued) 




















(link to documentation if available) Numerator/denominator description 
Admissions with 
primary diagnosis 










Yes Percentage of demonstration-eligible 
Medicare-Medicaid enrollees with a 
primary diagnosis of a severe and 
persistent mental illness or substance use 
disorder who are hospitalized 
Numerator: Total number of acute-care hospitalizations 
among demonstration-eligible Medicare-Medicaid 
enrollees, aged 18 or older with a primary diagnosis of 
a severe and persistent mental illness or substance use 
who are hospitalized.  
Denominator: Demonstration-eligible Medicare-







treatable ED visits 
Claims/encounter 




Yes Based on lists of diagnoses developed by 
researchers at the New York University 
Center for Health and Public Service 
Research, this measure calculates the rate 
of ED use for conditions that are either 
preventable/avoidable, or treatable in a 
primary care setting 
(http://wagner.nyu.edu/faculty/billings/
nyued-background). 
Numerator: Total number of ED visits with principal 
diagnoses defined in the NYU algorithm among 




department visits  
ED visits 
excluding those 








Yes Percentage of demonstration-eligible 
Medicare-Medicaid enrollees with an 
emergency department visit. 
Numerator: Total number of ED visits among 
demonstration-eligible Medicare-Medicaid enrollees 
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Table 16 (continued) 
































Yes Percentage of discharges for 
demonstration-eligible Medicare-
Medicaid enrollees who were 
hospitalized for selected mental health 
disorders and who had an outpatient 
visit, an intensive outpatient encounter, 
or partial hospitalization with a mental 
health practitioner. Two rates are 
reported: (1) The percentage of members 
who received follow-up within 30 days 
of discharge; (2) The percentage of 
members who received follow-up within 
7 days of discharge 
(http://www.qualityforum.org/QPS/). 
Numerator: Rate 1: (Among demonstration-eligible 
Medicare-Medicaid enrollees) an outpatient visit, 
intensive outpatient encounter, or partial hospitalization 
with a mental health practitioner within 30 days after 
discharge. Include outpatient visits, intensive outpatient 
encounters, or partial hospitalizations that occur on the 
date of discharge; Rate 2: (Among demonstration-
eligible Medicare-Medicaid enrollees) an outpatient 
visit, intensive outpatient encounter, or partial 
hospitalization with a mental health practitioner within 
7 days after discharge. Include outpatient visits, 
intensive outpatient encounters, or partial 
hospitalizations that occur on the date of discharge.  
Denominator: demonstration-eligible Medicare-
Medicaid enrollees who were discharged alive from an 
acute inpatient setting (including acute-care psychiatric 
facilities) in the measurement year. The denominator 
for this measure is based on discharges, not members. 
Include all discharges for members who have more than 
one discharge in the measurement year.  
Fall prevention 
Screening for Fall 
Risk 
Claims/encounter 
RTI will acquire 




Yes Percentage of demonstration-eligible 
Medicare-Medicaid enrollees under age 
65 who were screened for future fall risk 
at least once within 12 months 
Numerator: Demonstration-eligible Medicare-Medicaid 
enrollees who were screened for future fall risk at least 
once within 12 months.  
Denominator: All demonstration-eligible Medicare-
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Table 16 (continued) 




























CABG, PCI, CVA 
Claims/encounter 




Yes Percentage of demonstration-eligible 
beneficiaries evaluated in an outpatient 
setting who within the past 12 months 
have experienced AMI, CABG surgery, 
PCI, CVA, or cardiac transplantation, or 
who have CVA and have not already 
participated in an early outpatient CR 
program for the qualifying event/ 
diagnosis who were referred to a CR 
program. 
Numerator: Number of demonstration-eligible 
Medicare-Medicaid enrollees in an outpatient practice 
who have had a qualifying event/diagnosis in the 
previous 12 months who have been referred to an 
outpatient cardiac rehabilitation/secondary prevention 
program.  
Denominator: Number of demonstration-eligible 
Medicare-Medicaid enrollees in an outpatient clinical 
practice who have had a qualifying cardiovascular event 
in the previous 12 months, who do not meet any of the 
exclusion criteria, and who have not participated in an 












Yes Percentage of all demonstration-eligible 
long-stay residents in a nursing facility 
with an annual, quarterly, significant 
change, or significant correction MDS 
assessment during the selected quarter 
(3-month period) who were identified as 
high risk and who have one or more 
Stage 2–4 pressure ulcer(s).  
Numerators: Number of demonstration-eligible 
Medicare-Medicaid enrollees who are long-stay nursing 
facility residents who have been assessed with annual, 
quarterly, significant change, or significant correction 
MDS 3.0 assessments during the selected time window 
and who are defined as high risk with one or more 
Stage 2–4 pressure ulcer(s).  
Denominators: Number of demonstration-eligible 
Medicare-Medicaid enrollees who are long-stay 
residents who received an annual, quarterly, or 
significant change or significant correction assessment 
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Table 16 (continued) 



































Yes The percentage of demonstration-eligible 
Medicare-Medicaid enrollees with a new 
episode of alcohol or other drug (AOD) 
dependence who received the following: 
a. Initiation of AOD Treatment. The 
percentage who initiate treatment 
through an inpatient AOD admission, 
outpatient visit, intensive outpatient 
encounter or partial hospitalization 
within 14 days of the diagnosis. 
b. Engagement of AOD Treatment. The 
percentage who initiated treatment and 
who had two or more additional services 
with a diagnosis of AOD within 30 days 
of the initiation visit. 
(http://www.qualityforum.org/QPS/) 
Numerator: Among demonstration-eligible Medicare-
Medicaid enrollees (a) Initiation: AOD treatment 
through an inpatient admission, outpatient visit, 
intensive outpatient encounter or partial hospitalization 
within 14 days of diagnosis; (b) Engagement: AOD 
treatment and two or more inpatient admissions, 
outpatient visits, intensive outpatient encounters or 
partial hospitalizations with any AOD diagnosis within 
30 days after the date of the Initiation encounter 
(inclusive). Multiple engagement visits may occur on 
the same day, but they must be with different providers 
in order to be counted. Do not count engagement 
encounters that include detoxification codes (including 
inpatient detoxification) 
Denominator: Demonstration-eligible Medicare-
Medicaid enrollees age 13 years and older who were 
diagnosed with a new episode of alcohol and drug 
dependency during the intake period of January 1–
November 15 of the measurement year. 
EXCLUSIONS: Exclude those who had a 
claim/encounter with a diagnosis of AOD during the 60 
days before the IESD. For an inpatient IESD, use the 
admission date to determine the Negative Diagnosis 
History. For an ED visit that results in an inpatient stay, 
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Table 16 (continued) 




























RTI will acquire 




No Percentage of patients aged 18 and older 
screened for clinical depression using an 
age-appropriate standardized tool AND 





Numerator: Demonstration-eligible Medicare-Medicaid 
enrollees whose screening for clinical depression using 
an age-appropriate standardized tool AND follow-up 
plan is documented.  
Denominator: All demonstration-eligible Medicare-
Medicaid enrollees 18 years and older with certain 










No Percentage of members aged 18–85 who 
had a diagnosis of hypertension and 
whose blood pressure was adequately 
controlled (<140/90) during the 
measurement year 
(http://www.qualityforum.org/QPS). 
Numerator: Number of demonstration participants in 
the denominator whose most recent, representative BP 
is adequately controlled during the measurement year. 
For a member’s BP to be controlled, both the systolic 
and diastolic BP must be <140/90mm Hg.  
Denominator: Demonstration participants with 
hypertension. A patient is considered hypertensive if 
there is at least one outpatient encounter with a 
diagnosis of HTN during the first 6 months of the 
measurement year. 
Weight screening 






Prevention No Percentage of patients aged 18–74 years 
of age who had an outpatient visit and 
who had their BMI documented during 
the measurement year or the year prior to 
measurement. 
Numerator: BMI documented during the measurement 
year, or the year prior.  
Denominator: Demonstration-eligible Medicare-
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Table 16 (continued) 

























Prevention No Percentage of women 40–69 years of age 
and participating in demonstration who 
had a mammogram to screen for breast 
cancer. 
Numerator: Number of women 40–69 receiving 
mammogram in year.  










No Percentage of members 18+ who were 
diagnosed with a new episode of major 
depression and treated with antidepressant 
medication, and who remained on an 
antidepressant medication treatment. 
Numerator: Two rates are reported. (1) Effective acute 
phase treatment—newly diagnosed and treated 
demonstration participants who remain on 
antidepressant medication for at least 84 days. 
(2) Effective continuation phase treatment—newly 
diagnosed and treated demonstration participants who 
remained on antidepressant medication for at least 180 
days.  
Denominator: Newly diagnosed and treated 
demonstration participants over age 18. 













No Percentage of demonstration participants 
18–75 years of age with diabetes (type 1 
and type 2) who had each of the 
following: HbA1c control, LDL-C control, 
and retinal eye exam. 
Numerator: Number of these who had HbA1c control 
or LDL-C control, or retinal eye exam in year. 
Denominator: Demonstration participants 18–75 with 
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Table 16 (continued) 

































No Percentage who received at least 180 
treatment days of ambulatory medication 
therapy for a select therapeutic agent 
during the measurement year and at least 
one therapeutic monitoring event for the 
therapeutic agent in the measurement year. 
Agents measured: (1) ACE inhibitors or 
ARB, (2) digoxin, (3) diuretics, 
(4) anticonvulsants. 
Numerator: Number with at least 180 days of 
treatment AND a monitoring event in the 
measurement year. Combined rate is sum of 4 
numerators divided by sum of 4 denominators. 
Denominator: Demonstration participants with at least 
180 days of treatment in the year for a particular 
agent.  
ACE = angiotensin-converting-enzyme; ACSC = ambulatory care-sensitive conditions; AMI = acute myocardial infarction; AOD = alcohol or other drug; ARB = angiotensin II 
receptor blockers; BMI = body mass index; BP = blood pressure; CABG = coronary artery bypass graft; CHF = congestive heart failure; COPD = chronic obstructive pulmonary 
disease; CVA= cerebrovascular accident; ED = emergency department; HbA1c = Hemoglobin A1C; HEDIS = Healthcare Effectiveness Data and Information Set; HTN = 
hypertension; IESD = Index Episode Start Date; LDL-C = low-density-lipoprotein cholesterol (bad cholesterol); MDS = minimum data set; PCI = percutaneous coronary 
intervention; UTI = urinary tract infection. 
1 Impact estimates will be produced only for measures where data can also be obtained for the comparison group. Measures for which data are not expected to be available in the 
comparison group will be tracked only within the demonstration to measures changes over time. 
NOTE: Definitions, use, and specifications are as of 12/23/2013. 
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4.6 Cost 
To determine annual total costs (overall and by payer), we will aggregate the Medicare 
and Medicaid per member per month (PMPM) payments paid to the One Care plans and the 
costs for the eligible population who are not enrolled in the demonstration, per the intent to treat 
evaluation design. This approach will help us to detect overall cost impact and eliminate the 
effects of potential selection bias among beneficiaries who participate in the demonstration and 
those who opt out or disenroll. We will include Part D PMPM and any PMPM reconciliation 
data provided by CMS in the final assessment of cost impact to ensure that all data are available. 
The evaluation will analyze cost data for the service types shown in Table 14 in the 
previous section on utilization with the addition of prescription drug costs. We will present 
results for important subgroups, and in more detail to better understand their demonstration 
experience. We will also create a high-cost-user category and track costs of this group over time. 
To do this, we will measure the percentage of beneficiaries defined as high cost in Year 1 (e.g., 
those beneficiaries in the top 10 percent of costs). In subsequent years we will look at the 
percentage of beneficiaries above the Year 1 threshold to learn more about potential success in 
managing the costs of high-cost beneficiaries as a result of the demonstration. 
We will also evaluate cost savings for capitated model demonstrations twice during the 
demonstration, using a regression-based approach and the comparison group described in 
Section 4.2.2 of this report. The methodology for evaluating cost savings for capitated model 
demonstrations is currently under development and will be reviewed and approved by the CMS 
Office of the Actuary. We will also estimate cost savings accruing to the Medicare and Medicaid 
programs separately.  
4.7 Analytic Challenges 
Obtaining Medicaid fee-for-service data for the predemonstration and demonstration 
periods and One Care plan encounter data for the demonstration period will be critical for the 
evaluation. It will be important for Massachusetts to submit Medicaid fee-for-service data in a 
timely manner. It will also be important for CMS to continue to work with other States that may 
serve as comparison groups to update and maintain their MSIS/t-MSIS submissions. 
Additionally, in order to identify costs by service category, encounter data need to include 
pricing information. One Care plan encounter data are in the process of being finalized, so RTI 
will continue to work closely with CMS to understand the contents of the data provided by plans 
and how best these data can be utilized by the evaluation.
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